The detection of the concentration level of glucose or other analytes in certain individuals may be vitally important to their health. For example, the monitoring of glucose levels is particularly important to individuals with diabetes or pre-diabetes. People with diabetes may need to monitor their glucose levels to determine when medication (e.g., insulin) is needed to reduce their glucose levels or when additional glucose is needed.
Devices have been developed for automated in vivo monitoring of analyte concentrations, such as glucose levels, in bodily fluids such as in the blood stream or in interstitial fluid. Some of these analyte level measuring devices are configured so that at least a portion of the devices are positioned below a skin surface of a user, e.g., in a blood vessel or in the subcutaneous tissue of a user. As used herein, the term analyte monitoring system is used to refer to any type of in vivo monitoring system that uses a sensor disposed with at least a portion subcutaneously to measure and store sensor data representative of analyte concentration levels automatically over time. Analyte monitoring systems include both (1) systems such as continuous glucose monitors (CGMs) which transmit sensor data continuously or at regular time intervals (e.g., once per minute) to a processor/display unit and (2) systems that transfer stored sensor data in one or more batches in response to a request from a processor/display unit (e.g., based on an activation action and/or proximity, for example, using a near field communications protocol) or at a predetermined but irregular time interval.
Determining an analyte concentration level in blood based on the analyte concentration measured using an analyte monitoring system typically involves calibrating the in vivo sensor of the analyte monitoring system using a reference measurement. For example, a finger stick blood sample may be used as a reference to determine the blood analyte concentration at a particular time and the result is paired with a corresponding measurement from the analyte monitoring system. The sensitivity of the analyte monitoring system's sensor is adjusted based on the difference and other factors. However, several factors related to the measurement from the analyte monitoring system can affect the accuracy of the calibration. Thus, what is needed are systems, methods and apparatus to improve sensitivity calibration of the in vivo sensors used to measure analyte concentration.
Methods, devices, and systems are provided to improve sensitivity calibration of an in vivo analyte sensor and usability of the associated analyte monitoring system. In some embodiments, the present disclosure includes a computer-implemented method for defining a set of system checks associated with an analyte monitoring system; receiving a request to perform calibration of an in vivo sensor of an analyte monitoring system; receiving a signal representative of sensor data from the analyte monitoring system related to an analyte level of a patient measured over time; conducting calibration using a reference measurement estimated at calibration time from a first predetermined duration of reference observation paired, with a signal representative of sensor data up to the calibration time; updating calibration using the same reference measurement at a second predetermined duration of reference observation spanning the first predetermined duration and an additional period, paired with a signal representative of sensor data up to a third predetermined period relative to the calibration time; using an adjustment map that balances the risk of over and under calibration based on a priori information; deferring calibration if attenuation of a signal from the sensor is detectable at a time in which the request is received, wherein the calibration is delayed until the signal attenuation is no longer detected; performing calibration if the set of system checks pass and signal attenuation is not being detected; storing the signal from the sensor over time for a period of time spanning from before the calibration to after the calibration; determining if previously undetected signal attenuation occurred during the calibration based on the stored signal after the calibration has completed; reconstructing the signal and revising the calibration of the sensor based on the reconstructed signal if previously undetected signal attenuation occurred and if the signal can be adjusted to compensate for the previously undetected signal attenuation; invalidating the calibration and requesting a new calibration if previously undetected signal attenuation occurred and if the signal cannot be adjusted to compensate for the previously undetected signal attenuation; and displaying an analyte concentration value if previously undetected signal attenuation did not occur during calibration based on the stored signal. Related systems and computer program products are also disclosed. Numerous other aspects and embodiments are provided. Other features and aspects of the present disclosure will become more fully apparent from the following detailed description, the appended claims, and the accompanying drawings.
The present disclosure provides systems, methods, and apparatus to improve sensitivity calibration of an in vivo analyte sensor and usability of the associated analyte monitoring system. In some embodiments, the present disclosure provides methods that improve the user experience of using an analyte monitoring system. For example, in some embodiments, the present disclosure includes features that reduce the amount of calibration or re-calibration performed by the analyte monitoring system. More specifically, in some embodiments, the present disclosure provides methods of using a suspect calibration attempt to avoid having to recalibrate by adjusting the calibration or mitigating effects of sensor signal attenuation that caused the calibration attempt to be suspect. For example, sensor signal attenuating phenomena such as Early Sensitivity Attenuation (ESA) and dropouts that occur during a calibration attempt (and render the calibration attempt suspect) can be addressed in some embodiments. When ESA or a dropout occurs, the sensor still generates a signal with a lower amplitude than the true signal, but may still take on a value that is physiologically feasible. Hence, unlike signal loss, detection of either ESA or a dropout is not trivial. Unlike typical noise artifact, ESA and dropouts consistently bias the sensor output down. Standard filtering methods are not effective to compensate for neither ESA nor dropouts without incurring additional drawbacks. ESA typically occurs within the first few hours of sensor start time, and disappears thereafter. Dropouts last for much shorter periods and might occur, for example, during bedtime independent of the sensor start time.
In some embodiments, the present disclosure provides methods of analyzing sensor data received after a reference analyte concentration value is received (e.g., initiated by the user) to perform a calibration in place of a future system requested calibration. Thus, for example, if a user happens to perform a finger stick in vitro blood glucose (BG) measurement and the outcome is provided to the analyte monitoring system, the system can use the information as a reference analyte concentration value for a calibration attempt. In conventional BG systems, a reference analyte BG reading is computed based on a time series measurement in response to an analyte sample collected in a test strip. The BG system takes a predetermined duration in order to collect the time series measurement, typically in the five second range. In addition, instead of determining a sensitivity of the in vivo sensor using a real time algorithm that only considers limited sensor data in order to provide real time responsiveness regarding the success or failure of the calibration attempt, the present disclosure can take the time to consider a wider window of sensor data since the user is not waiting for an outcome indication of the calibration attempt. Therefore, not only are the number of system requested calibrations reduced, more accurate calibrations can be performed by using more data. In some embodiments, the present disclosure provides methods that improve the sensitivity calibration by using historical data to hedge against the aggregate risks of calibration errors, such as, for example, due to ESA. In some embodiments, the present disclosure uses “extra” data obtained from a test strip that remains in a BG meter after an initial reading has been made, to improve the accuracy of the initial reading and to improve the certainty of the analyte monitoring system's calibration based on the initial reading. In some embodiments, the present disclosure uses fault identification, instead of merely detecting faults, to improve the likelihood of a successful calibration attempt.
Embodiments of the present disclosure are described primarily with respect to continuous glucose monitoring devices and systems for illustrative purposes but the present disclosure can be applied to other analytes, other analyte characteristics, and other analyte measurement systems, as well as data from measurement systems that transmit sensor data from a sensor unit to another unit such as a processing or display unit in response a request from the other unit. For example, other analytes that can be monitored include, but are not limited to, acetyl choline, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, DNA, fructosamine, glutamine, growth hormones, hormones, ketones, lactate, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, and troponin. The concentration of drugs, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), digitoxin, digoxin, drugs of abuse, theophylline, and warfarin, can also be monitored. In those embodiments that monitor more than one analyte, the analytes can be monitored at the same or different times. In addition, in some embodiments, the present disclosure can be applied to non-analyte sensor data. For example, non-analyte sensor data can include temperature estimation of a target physiological compartment that is made based on measuring the temperature of a nearby compartment, where the measured temperature is related to the temperature of the target compartment. The present disclosure also provides numerous additional embodiments.
Some embodiments of the present disclosure include a programmed computer system adapted to receive and store data from an analyte monitoring system. The computer system can include one or more processors for executing instructions or programs that implement the methods described herein. The computer system can include memory and persistent storage devices to store and manipulate the instructions and sensor data received from the analyte monitoring system. The computer system can also include communications facilities (e.g., wireless and/or wired) to enable transfer of the sensor data from the analyte monitoring system to the computer. The computer system can include a display and/or output devices for identifying dropouts in the sensor data to a user. The computer system can include input devices and various other components (e.g., power supply, operating system, clock, etc.) that are typically found in a conventional computer system. In some embodiments, the computer system is integral to the analyte monitoring system. For example, the computer system can be embodied as a handheld or portable receiver unit within the analyte monitoring system. In some embodiments, the analyte monitoring system may include a computer system and in some embodiments, the analyte monitoring system may include (or be in signal communication with) an analyte meter (e.g., a BG meter) configured to measure an analyte concentration in vitro.
In some embodiments, the various methods described herein for performing one or more processes, also described herein, can be embodied as computer programs (e.g., computer executable instructions and data structures). These programs can be developed using an object oriented programming language, for example, that allows the modeling of complex systems with modular objects to create abstractions that are representative of real world, physical objects and their interrelationships. However, any practicable programming language and/or techniques can be used. The software for performing the inventive processes, which can be stored in a memory or storage device of the computer system described herein, can be developed by a person of ordinary skill in the art based upon the present disclosure and can include one or more computer program products. The computer program products can be stored on a non-transitory computer readable medium such as a server memory, a computer network, the Internet, and/or a computer storage device.
Analyte monitoring systems such as Continuous Glucose Monitor (CGM) systems that use reference Blood Glucose (BG) values for calibration, pair the reference BG values with a corresponding sensor data point received in an uncalibrated sensor signal from the CGM system. There are a number of conditions which can invalidate a calibration attempt due to known hardware system, environmental, and physiological factors. A hardware system invalidating factor example includes the sensor signal transmission to the receiver, handheld, or monitoring unit has been compromised with noise or interrupted altogether. A potential environmental invalidating factor example occurs when a measured temperature is out of the operating range of the system. A physiological invalidating example occurs when the computed rate is too high, either physiologically so, such that the accuracy of certain numerical calculations can be suspect, or non-physiologically high such that the reliability of the latest sensor signal is questionable.
Temporal features of the sensor signal that do not correlate to glucose excursion can significantly affect calibration. Examples of such temporal features include Early Sensitivity Attenuation (ESA) and dropouts. Methods to detect and evaluate these features during operation of the analyte monitoring system as they occur (i.e., in real time) allows the system to determine the proper course of action. For example, if a dropout is determined to be taking place while the system is scheduled to perform a calibration, the system can delay the calibration request until the undesired artifact is deemed to have ended. On occasion, re-evaluating data from before and up to after a completed calibration can reveal that the completed calibration actually took place while an undesired temporal feature, such as a dropout, occurred. This retrospective conclusion can result in two possible scenarios. The first is that the errors in calibration due to the dropout can be corrected, so that the system revises the calibration in light of this new information. The second is that the errors in calibration due to the dropout cannot be corrected. In this case, the system may decide to invalidate the recently performed calibration either immediately or within a certain elapsed time after this determination. When the recently performed calibration is invalidated, the system will determine when to request a new calibration based on various factors including the likelihood of the persistence of undesired temporal features.
In some embodiments, the present disclosure attempts to adjust the calibration and/or mitigate the effect of temporal signal attenuations on calibration. By combining existing calibration checks and calculations with retrospective calibration and both real-time and retrospective artifact detection, such as for example, using a dropout detector, the present disclosure is able to salvage suspect calibration attempts that might otherwise require additional calibration.
Turning now to
If undesired signal attenuation is detected, the system will delay the calibration request until the sensor has recovered and a true signal is generated. Otherwise, the system will allow calibration provided that other system checks are passed (110). The system stores the sensor data from before and after the calibration (112). Within a predetermined time after a calibration has been performed, the system retrospectively evaluates the sensor's signal quality around the moment of calibration to determine whether a previously undetected undesired signal attenuation was missed by the real-time detector(s) (114). If an undesired signal attenuation is determined to have taken place during the calibration, and if the true analyte signal can be reconstructed with good confidence, then the system revises the result of the calibration without the need of further user interaction (116). An example of such retrospective calibration is described in U.S. Pat. No. 7,618,369 entitled “Method and System For Dynamically updating Calibration Parameters For an Analyte Sensor” and incorporated herein by reference. However, if an undesired signal attenuation is determined to have taken place and the true analyte signal cannot be reconstructed with good confidence, then the system may request a new calibration (118).
In some embodiments, the system can take alternative courses of action depending on the characterization of the attenuation. In order to characterize attenuation, a detector estimates the degree of attenuation during a window of time by comparing the measured aggregate level of the signal in that window relative to a baseline level, which is computed from the same window of time using a different filter, or computed from a different window of time using a similarly structured filter. The comparison between the measured aggregate level and the baseline level is used to identify whether or not an attenuation is occurring. If adjacent time windows are deemed to be attenuated, then the time windows may be considered as a single attenuation event. For each event, a predicted time of onset and recovery may be computed. Some of the characterizations of attenuation include the direct ratio between the measured aggregate level and its baseline, a scaled ratio between the measured aggregate level and its baseline, a function such as a quadratic absolute ratio between the measured aggregate level and its baseline, the peak ratio, the duration between onset and recovery, or the area under the curve generated by the ratio and duration. One or more of these characterizations can be used to determine the various courses of action needed. If the attenuation completely invalidates the previously completed calibration, then the system can immediately expire that calibration, and the system may no longer display an analyte concentration value until a successful calibration has been performed. If the calibration is sufficiently accurate enough to provide useful analyte concentration value information for at least a short time after the calibration, the system momentarily allows the analyte concentration value display to continue, and then expires the calibration soon after. When appropriate, the system requests a new calibration in order to resume display of the analyte concentration value (120).
In some embodiments, in addition to compensating for signal attenuation, the methods of the present disclosure can assess the feasibility of a calibration attempt based on past and stored data to identify faults. Thus, instead of merely invalidating a calibration attempt because a check has failed, the present disclosure can determine useful information to avoid repeating failed calibrations in the future. The present disclosure assesses the sensor signal and reference analyte value history around the present and past calibration attempts. In some embodiments, the present disclosure determines whether a current failed calibration attempt is caused by the sensor currently producing unreliable sensor data, or whether the reference analyte concentration value is not reliable.
To illustrate the additional information provided by checking the reference value and the sensor data instead of just the sensitivity value, consider a case in which the latest calibration attempt is close enough to a prior attempt, whether or not the prior attempt was used to update sensitivity for glucose calculation. In addition to the system checks, these relatively closely spaced reference values can be compared to assess the feasibility of the reference value of the latest calibration attempt. For example, if the difference between the latest and previous reference values is too large considering the time interval between them and the assumed reference value measurement error variability, then the latest calibration attempt should be failed, even though none of the sensitivity based checks failed. In some cases, an outlier reference value could occur such that the sensitivity happens to be relatively unchanged because the error in reference value is almost cancelled by another erroneous factor in the calculation of sensitivity.
If there are several recent past reference value data available, other methods can be used. One example is to monitor the standard deviation of the predicted reference value using a regularization procedure or other data smoothing procedure. A dramatic increase in standard deviation around the latest attempt implies that the latest reference value has a relatively large uncertainty.
In addition to using reference value, one can make a better assessment of the latest calibration attempt by considering the sensor data. For example, given the best sensitivity used up to the latest attempt, the computed analyte level can be compared from the sensor data around the instances where recent past calibration attempts were made. The computed analyte level can then be tested against similar methods as described in the previous section. In addition, methods that require relatively constant sample time, such as an Auto Regressive (AR) model and Auto Regressive Moving Average (ARMA), can be used to see whether the latest sensor measurements correlated reasonably well to past data in the same manner as observed around the recent past attempts. Because of the relatively rich data content from the sensor, assessments can be made involving combinations of point wise analyte values as well as higher order signals. For example, one can track the analyte rate of change during recent past and latest calibration attempts, to determine whether including the latest calibration attempt significantly changes the rate distribution statistics of the moving average population.
The likelihood of undesired sensor transients can be checked to see if they differ dramatically between the latest attempts. For example, assuming a dropout detector is used to assess the likelihood of the sensor signal exhibiting dropouts, if the detector generates a much higher likelihood for dropouts than the previous attempts, then it is possible that at least the absolute raw sensor signal and/or the raw sensor rate of change may be far enough from the true value that a sensitivity check may not indicate an actual change in sensitivity. The combined knowledge of the relative confidence of the sensor, reference BG, and the resulting sensitivity calculation amongst relatively recent attempts can be useful in a number of ways. For example, the reference value and sensor signal comparisons are useful in qualifying the relative uncertainty of calibration attempts. By taking the combined information, one can weigh both the reference BG and sensor signal of recent past attempts, so that future calibration attempts can be compared against these values without having to resort to using equal weighting for each of the attempts. This results in a more reliable relative assessment. In some embodiments, the relative weighting can be used when generating the latest weighted sensitivity to be used in converting raw sensor signal into final glucose values as well as glucose rate of change. In other words, instead of using a fixed weighting factor that was predetermined offline, each calibration update can use all near past and latest attempts with weights that are derived from the combination of the above comparisons.
Additionally, a consistent pattern of increase or change in uncertainty over time of the sensor signal, reference value, or computed sensitivity can be used to infer that state of the system. Several possible scenarios and corresponding system actions are described below. For example, if the latest few attempts indicate that the sensor signal or sensor rate of change uncertainty increases dramatically compared to the older attempts, the system could conclude that the sensor is momentarily not ready to produce reliable measurements. The system could notify the user to delay the follow-up calibration attempt in order not to waste their effort. The delay time may depend on other checks, such as the various components of data quality check as well as the ESA detector. If the last attempt indicates that the latest reference value uncertainty is dramatically larger compared to the other past attempts, the system could conclude that the attempt must be failed because the latest reference value is likely to be an outlier. The system could notify the user to try again, possibly reminding the user to consult the user guide for the proper finger stick method.
If more than one recent reference value attempts show a relatively larger uncertainty than the older records, then the system can conclude that something systematic could be wrong with the reference value measurement process. Examples include using a new test strip vial but not correctly updating the sensor code, using alternate site testing (AST) without properly preparing the test area, and possibly using control solution instead of patient's blood as a sample source. The system could remind the user to consult the user guide for the proper finger stick method. If the persistent increase in uncertainty is too big, the system may decide to terminate operation to prevent producing results with poor accuracy.
If more than one attempt indicate that while both the reference value and the sensor signal are relatively reasonable, but the latest computed sensitivities result in a much larger uncertainty than before, then it is possible that a dramatic change has occurred. One possible cause would be a change in the effective dynamics between, for example, blood and interstitial glucose, such that the reference value and interstitial analyte value independently show no dramatic change in behavior, but their dynamic and possibly static relationship has changed. Another possible cause would be the loss of counter electrode function, in which a bias is introduced between measured interstitial analyte and blood analyte as measured by the reference value. In some embodiments, the system could elect to adjust the calibration factor with an offset factor as necessary. If several follow-up confirmatory finger sticks do not indicate that the offset-adjusted model has a good fit, then the system may decide to terminate operation.
Turning now to
In some embodiments, an analyte monitoring system is provided configured to request a reference analyte concentration value for use in calibrating an in vivo sensor of the analyte monitoring system (302). The request may be satisfied by a user-initiated supply of the reference analyte concentration value before the request or by a user response to the request. A signal representative of sensor data is received from the analyte monitoring system related to an analyte level of a patient measured over time (304). A first method of computing a sensitivity value for calibrating the sensor is provided wherein the sensitivity value is computed based on an amount of sensor data that is less than a predetermined amount (306). A second method of computing a sensitivity value for calibrating the sensor is provided wherein the sensitivity value is computed based on an amount of sensor data that is more than a predetermined amount (308). The sensor is calibrated using the first method when the request is satisfied by a user response to the request (310). The sensor is calibrated using the second method when the request is satisfied by a user initiated supply of the reference analyte concentration before the request (312). The analyte level of the patient is displayed based on the calibration of the sensor (314).
In some embodiments, the system attempts a full retrospective calibration on a first BG measurement and a partial and/or real-time calibration on a second BG measurement as soon as a scheduled calibration is required. The result can be a weighted average based on the relative uncertainty of the two results. In some embodiments, the weighting scheme can be dependent on the percentage of data points available to perform retrospective calibration. Once a weighted average of the two calibration values are obtained, then the system can use that value as the calibration value and the user will be relieved of having to take a measurement for the next scheduled calibration. If one of the values fails a calibration-related acceptance criteria, then the system ignores that value. If none of the values pass the system checks, then the normally scheduled calibration will occur.
In some embodiments, the system can wait for the second user-initiated BG measurement to have sufficient associated sensor data so that retrospective calibration can be performed on both user-initiated BG measurements without attempting a real-time calibration. If both calibrations pass the calibration-related acceptance criteria, then the weighted average will be used as the calibration value for the next scheduled calibration. If one calibration fails, then only the successful calibration is used. If both fail, then the normally scheduled calibration will occur.
In some embodiments, any user-initiated BG measurements prior to a next scheduled calibration can be used to update calibration parameters that are used to screen out unsuitable conditions. For example, pre-calibration screening routines may check the glucose rate of change based on an assumed sensitivity value and the analyte monitoring system's sensor signal close in time to a next scheduled calibration. Updating the sensitivity value using the user-initiated BG measurements can improve the reliability of such a pre-calibration screening routine, thereby reducing the frequency of unnecessary calibration requests that have a relatively elevated chance of failure. In some embodiments, any user-initiated BG measurement taken just prior to a BG measurement initiated by the system (e.g., a system requested measurement) for a next scheduled calibration, can be combined to obtain calibration results that are relatively insensitive to BG measurement errors, an analyte monitoring system sensor signal noise, and potential changes in system equilibrium since the last scheduled calibration. In some embodiments, the decision to use any one or combination of the above embodiments can be determined by a processor-based online logic system and/or by using rules derived offline from analysis of stored data. For example, the system can determine that a stepwise change in one or more system related parameters may be likely around the third to fourth day of the sensor wear.
In another aspect of the present disclosure, the system may take advantage of additional data available when a test strip is left in a reference BG meter beyond the time required by the meter's primary algorithm to determine a reference analyte concentration value. This extended time during which an analyte measurement system with an integrated reference BG meter would not normally monitor the output of the reference BG meter can be used to refine or improve the initial determination of the reference analyte concentration value by using the additional data. A second algorithm allows for an updated reference analyte concentration value and the uncertainty limits can be used by the analyte measurement system to further refine its calibration value.
In some embodiments, for each calibration instance, the primary algorithm produces a reference BG value to be used by the analyte measurement system's calibration algorithm. The reference BG value, together with the most recent sensor signal measurements, can be used to both evaluate the suitability of the current calibration attempt and to obtain the sensitivity (i.e., a scaling calibration factor), in order to produce an analyte measurement from the analyte measurement system. Immediately after, the second algorithm can use data from the existing primary algorithm plus any further signal from the BG meter's strip port until the strip is removed. The second algorithm then provides an updated reference BG value to the analyte measurement system's calibration algorithm, which uses the updated reference BG value to refine the sensitivity value. The update can occur several minutes after the test strip has been removed and requires no special action by the user.
In some embodiments a stream of recursive revisions of the reference BG meter glucose estimate is used to obtain a measure of the measurement's variability. The variability in the reference BG meter glucose value can then be translated into the variability of the computed sensitivity for calibration. This results in both upper and lower bounds of the estimated sensitivity. Knowing these bounds allow the relative precision of each calibration to be compared. In addition, any threshold checks could be done with these bounds taken into account. For example, if the latest rate check results in an estimate of 1.9±0.5 mg/(dL min), then a +2 mg/(dL min) maximum rate threshold may be too close for the latest calibration attempt to be allowed to succeed.
In some embodiments, the reference BG meter variability is first obtained by comparing the characteristics of a primary reference BG meter algorithm against the secondary reference BG meter algorithm operating at different extended time durations. These measurements are also compared against the known glucose concentration in the medium that the reference BG meter strip takes its measurement from. Any possible bias and offset correction as a function of the difference between the primary and secondary reference BG meter algorithm outputs as well as the duration of the extended time, can then be used to correct the reference BG meter reading used for calibration in the analyte measurement system. This online correction will be applied as soon as the secondary reference BG meter algorithm finishes. The calibration algorithm in the analyte measurement system can then be used to revise the sensitivity value based on the bias and/or offset adjusted reference BG meter reading.
In some embodiments, the correlation between the degree of certainty of a reference BG meter reading and the difference between primary and secondary reference BG meter algorithm outputs as a function of extended time duration is obtained. In an online implementation, as soon as the secondary reference BG meter algorithm finishes, the weighting of the latest sensitivity value can be adjusted by taking into account for the degree of certainty obtained offline.
Turning now to
The stratification based on Sc/Sm ratio shown in
Given the equal 10% increments, it can be observed that the performance degradation in terms of marginal increase in full MARD, marginal increase in the absolute value of low end MRD, and the marginal decrease in Percent A, moves faster for the groups below the median than for the groups above the median. Practically, this means that based on the common accuracy performance metrics, the system is much more robust to a high sensitivity calibration compared to a low sensitivity calibration of the same additive percentage change. This is still the case if the comparison were to be made in the geometric percentage change sense. For example, the group where Sc/Sm is less than or equal to 0.8 should be geometrically comparable to the group where Sc/Sm is greater than or equal to 1/0.8=1.25. One would expect that this group would lie between the 1.2 and 1.3 groups in
In the general context of calibration, it can be assumed that the effective sensitivity being somewhat higher than computed is preferred over using the “as is” value or a mildly scaled down value. This observation can be combined with real-time observations of past calibrations as well as aggregate sensor sensitivity information obtained from the manufacturing lot to improve the robustness of each calibration instance. In the particular case related to ESA, where early sensitivity calculations are most likely to be underestimated, a proper scaling of this calculated value could mean improved accuracy.
Prior information regarding the sensor based on past calibrations and/or sample lot statistics is used to obtain the best nominal estimate of the sensor sensitivity. Any statistical property of this estimate, such as mean and standard deviation, can be adjusted by the risk distribution derived by information obtained from the process summarized in
Ga=Kc Gr/Sc, where Kc is the inverse of the Accuracy Metric.
For an additive accuracy metric such as Mean Difference, the adjustment is:
Ga=(Gr/Sc)+Kc, where Kc is the negative of the Accuracy Metric.
For subsequent calibrations, the latest function or lookup table is used to determine the necessary calibration correction (1014). The method 1000 repeats if new data becomes available (1016) or otherwise uses the latest function or lookup table (1018).
Accordingly, in certain embodiments, a computer-implemented method includes receiving a signal representative of sensor data from an analyte sensor configured to monitor an analyte level over time, calibrating the analyte sensor if attenuation of the received signal from the analyte sensor is not detectable, deferring calibration of the analyte sensor if attenuation of the received signal from the analyte sensor is detectable when calibration is requested, wherein the calibration is deferred until the attenuation of the received signal is no longer detected, storing the signal from the analyte sensor for a period of time spanning from before the calibration to after the calibration, determining whether a previously undetected signal attenuation has occurred during the calibration based on the stored signal after the calibration has been completed, performing reconstruction of the received signal based on the stored signal from the analyte sensor for the period of time spanning from before the calibration to after the calibration, when it is determined that the previously undetected signal attenuation has occurred, to generate a reconstructed signal, updating the calibration of the analyte sensor based on the reconstructed signal, and invalidating the calibration of the analyte sensor and requesting a new calibration of the analyte sensor if performing the reconstruction of the received signal does not generate the reconstructed signal.
Certain embodiments further include displaying an analyte concentration value corresponding to the monitored analyte level if the previously undetected signal attenuation did not occur during calibration based on the stored signal, or if performing the reconstruction of the received signal generated the reconstructed signal.
Certain embodiments also include suspending displaying the analyte concentration value if the calibration of the analyte sensor is invalidated and the previously undetected signal attenuation is greater than a predefined threshold.
Certain embodiments further include displaying an analyte concentration value when the new calibration is performed and the previously undetected signal attenuation is less than a predefined threshold.
Certain embodiments further include delaying invalidating the calibration if the signal attenuation is determined to be continuing to occur.
In certain embodiments, deferring calibration if attenuation of the signal from the analyte sensor is detectable further includes detecting signal attenuation from at least one of a hardware system condition, an environmental condition, and a physiological condition.
In certain embodiments, deferring calibration if attenuation of the signal from the analyte sensor is detectable further includes detecting signal attenuation from at least one of early signal attenuation and a dropout.
A system for monitoring an analyte using an in vivo sensor in accordance with an embodiment of the present disclosure includes a processor, a memory operatively coupled to the processor, the memory storing instructions which, when executed by the processor, causes the processor to: receive a signal representative of sensor data from an analyte sensor configured to monitor an analyte level over time, calibrate the analyte sensor if attenuation of the received signal from the analyte sensor is not detectable, defer calibration of the analyte sensor if attenuation of the received signal from the analyte sensor is detectable when calibration is requested, wherein the calibration is deferred until the attenuation of the received signal is no longer detected, store the signal from the analyte sensor for a period of time spanning from before the calibration to after the calibration, determine whether a previously undetected signal attenuation has occurred during the calibration based on the stored signal after the calibration has been completed, perform reconstruction of the received signal based on the stored signal from the analyte sensor for the period of time spanning from before the calibration to after the calibration, when it is determined that the previously undetected signal attenuation has occurred, to generate a reconstructed signal, update the calibration of the analyte sensor based on the reconstructed signal, and invalidate the calibration of the analyte sensor and request a new calibration of the analyte sensor if performing the reconstruction of the received signal does not generate the reconstructed signal.
A computer program product stored on a computer-readable medium in accordance with one embodiment of the present disclosure includes instructions to: receive a signal representative of sensor data from an analyte sensor configured to monitor an analyte level over time, calibrate the analyte sensor if attenuation of the received signal from the analyte sensor is not detectable, defer calibration of the analyte sensor if attenuation of the received signal from the analyte sensor is detectable when calibration is requested, wherein the calibration is deferred until the attenuation of the received signal is no longer detected, store the signal from the analyte sensor for a period of time spanning from before the calibration to after the calibration, determine whether a previously undetected signal attenuation has occurred during the calibration based on the stored signal after the calibration has been completed, perform reconstruction of the received signal based on the stored signal from the analyte sensor for the period of time spanning from before the calibration to after the calibration, when it is determined that the previously undetected signal attenuation has occurred, to generate a reconstructed signal, update the calibration of the analyte sensor based on the reconstructed signal, and invalidate the calibration of the analyte sensor and request a new calibration of the analyte sensor if performing the reconstruction of the received signal does not generate the reconstructed signal.
Certain embodiments include a computer-implemented method comprising defining a set of system checks associated with an analyte monitoring system, receiving a signal representative of sensor data from an analyte monitoring system related to an analyte level of a patient measured over time, receiving a reference analyte concentration value, calculating a sensitivity value based on the signal and the reference analyte concentration value, performing the system checks on the sensitivity value, determining if the signal is a cause of the sensitivity value being invalid if the system checks indicate the sensitivity value is invalid, determining if the reference analyte concentration value is a cause of the sensitivity value being invalid if the system checks indicate the sensitivity value is invalid, recalculating the sensitivity value using new sensor data after a delay if the signal was a cause of the sensitivity value being invalid, recalculating the sensitivity value using a new reference analyte concentration value if the reference analyte concentration value was a cause of the sensitivity value being invalid, and displaying the analyte level of the patient based on the recalculated sensitivity value if the system checks indicate the sensitivity value is invalid.
In certain embodiments, determining if the reference analyte concentration value is a cause of the sensitivity value being invalid includes determining if a difference between the reference analyte concentration value and a prior reference analyte concentration value is larger than a predefined threshold amount wherein the prior reference analyte concentration value was received within a predefined time period of the reference analyte concentration value.
In certain embodiments, determining if the reference analyte concentration value is a cause of the sensitivity value being invalid includes determining if a difference between a standard deviation of the reference analyte concentration value and a standard deviation of a predicted reference analyte concentration is larger than a predefined threshold amount, wherein the standard deviation of the predicted reference analyte concentration is determined based on a plurality of prior reference analyte concentration values.
In certain embodiments, determining if the signal is a cause of the sensitivity value being invalid includes determining if a difference between the signal and a prior signal received during a prior calculation of a sensitivity value is larger than a predefined threshold amount wherein the prior signal was received within a predefined time period of the signal.
In certain embodiments, determining if the signal is a cause of the sensitivity value being invalid includes determining if the signal correlates with prior signals received during prior calculations of sensitivity values to within a predetermined amount.
In certain embodiments, determining if the signal is a cause of the sensitivity value being invalid includes determining if including the signal in a moving average population of prior signals received during prior calculations of sensitivity values changes a rate of change distribution of the moving average population by more than a predetermined threshold.
Certain embodiments may further comprise calculating a weighting of the sensitivity value indicative of a relative confidence rating of the accuracy of the sensitivity value, wherein the weighting is determined based on the signal and the reference analyte concentration value compared to prior signals and the reference analyte concentration values received during prior calculations of sensitivity values.
Certain embodiments include a computer-implemented method comprising providing an analyte monitoring system configured to request a reference analyte concentration value for use in calibrating an in vivo sensor of the analyte monitoring system, wherein the request may be satisfied by a user initiated supply of the reference analyte concentration value before the request or by a user response to the request, receiving a signal representative of sensor data from the analyte monitoring system related to an analyte level of a patient measured over time, providing a first method of computing a sensitivity value for calibrating the sensor wherein the sensitivity value is computed based on an amount of sensor data that is less than a predetermined amount, providing a second method of computing a sensitivity value for calibrating the sensor wherein the sensitivity value is computed based on an amount of sensor data that is more than a predetermined amount, calibrating the sensor using the first method when the request is satisfied by a user response to the request, calibrating the sensor using the second method when the request is satisfied by a user initiated supply of the reference analyte concentration before the request, and displaying the analyte level of the patient based on the calibration of the sensor.
In certain embodiments, if the user initiated supply of the reference analyte concentration occurs within a predetermined time before the request, the sensor is calibrated using the first method.
In certain embodiments, if the user supplies a reference analyte concentration before the request and a second reference analyte concentration in response to the request, a sensitivity value is computed for each analyte concentration and a weighted average of the sensitivity values is used for calibration.
In certain embodiments, if the user supplies two or more reference analyte concentrations before the request, a sensitivity value is computed for each analyte concentration and a weighted average of the sensitivity values is used for calibration.
In certain embodiments, if the user initiated supply of the reference analyte concentration occurs within a predetermined time before the request and a sensitivity value based on the second method passes an acceptance criteria, the system cancels the request and the sensor is calibrated using the second method.
Certain embodiments may further comprise defining a set of acceptance criteria for using a sensitivity value to calibrate the sensor, wherein if the user supplies two or more reference analyte concentrations, a sensitivity value is computed for each analyte concentration and the sensor is calibrated based on only sensitivity values that pass the acceptance criteria.
Certain embodiments include a computer-implemented method comprising providing an analyte monitoring system configured to receive a reference analyte concentration value for use in calibrating an in vivo sensor of the analyte monitoring system, wherein the reference analyte concentration value is calculated based on a test strip inserted in a port of an in vitro analyte meter for a predetermined period of time, receiving a signal representative of sensor data from the analyte monitoring system related to an analyte level of a patient measured over time, providing a first method of calculating the reference analyte concentration value wherein the reference analyte concentration value is calculated based on data collected from the test strip within the predetermined period of time, providing a second method of calculating the reference analyte concentration value wherein the reference analyte concentration value is calculated based on data collected from the test strip within the predetermined period of time and data collected from the test strip after the predetermined period of time, computing a sensitivity value for calibrating the sensor based on the reference analyte concentration value computed using the first method, re-computing the sensitivity value for calibrating the sensor based on the reference analyte concentration value computed using the second method if the test strip remains in the port of the in vitro analyte meter beyond the predetermined period, calibrating the sensor using the sensitivity value, and displaying the analyte level of the patient based on the calibration of the sensor.
Certain embodiments may further comprise determining a first value indicative of a variability of the reference analyte concentration value; determining a second value indicative of a variability of the sensitivity value based on the first value; and verifying validity of a subsequent calibration attempt using a subsequently computed sensitivity value based on the second value.
Certain embodiments may further comprise recursively re-computing the reference analyte concentration value based on data collected from the test strip within the predetermined period of time and data collected from the test strip after each additional passage of the predetermined period of time or fraction thereof.
In certain embodiments, re-computing the sensitivity value includes using a weighted average of the reference analyte concentration values computed using the first method and the second method.
In certain embodiments, the weighting is determined based upon historical differences between reference analyte concentration values computed using the first method and the second method.
In certain embodiments, the historical differences between reference analyte concentration values computed using the first method and the second method include reference analyte concentration values computed using the second method wherein the test strip remains in the port of the in vitro analyte meter for varying amounts of time.
Certain embodiments include a computer-implemented method comprising providing an analyte monitoring system configured to receive a reference analyte concentration value for use in calibrating an in vivo sensor of the analyte monitoring system, wherein the reference analyte concentration value is calculated based on a test strip inserted in a port of an in vitro analyte meter for a first predetermined period of time, receiving a signal representative of sensor data from the analyte monitoring system related to an analyte level of a patient measured over time, pairing the reference analyte concentration value with the sensor data in real time during the first predetermined period of time, calculating a first sensitivity value based on the reference analyte concentration value from the in vitro analyte meter during the first predetermined period of time, recursively updating the first sensitivity value for as long as the test strip remains in the port and can provide updated reference analyte concentration values, calculating a final sensitivity value after a second predetermined period of time based on sensor data up to the second predetermined time, paired with an updated reference analyte concentration value from a most recent recursive update.
In certain embodiments, the first predetermined period of time is approximately 3 seconds to approximately 10 seconds and wherein the second predetermined period of time is approximately 3 minutes to approximately 15 minutes.
Certain embodiments include a computer-implemented method comprising providing an analyte monitoring system configured to receive a reference analyte concentration value for use in calibrating an in vivo sensor of the analyte monitoring system, providing a nominal estimate of a sensitivity of the sensor based on at least one of past calibrations and sample lot statistics, adjusting one or more statistical properties of the nominal estimate based on a risk distribution, receiving a signal representative of sensor data from the analyte monitoring system related to an analyte level of a patient measured over time, computing a current sensitivity based on the reference analyte concentration value and the sensor data, determining a table of correction factors for each past calibration based on a comparison of a current sensitivity with prior sensitivity values, applying a correction factor from the table of correction factors to the computed current sensitivity to determine a corrected sensitivity, and displaying an analyte level of a patient based on the sensor being calibrated using the corrected sensitivity.
In certain embodiments, the risk distribution is derived by stratifying paired sensor data and reference analyte concentration values plotted on a Clarke Grid based on a ratio of sensor sensitivity during calibration and an estimate of true sensor sensitivity.
Certain embodiments include a computer-implemented method comprising providing an analyte monitoring system configured to receive a reference analyte concentration value for use in calibrating an in vivo sensor of the analyte monitoring system, receiving a signal representative of sensor data from the analyte monitoring system related to an analyte level of a patient measured over time, storing sensor data, calibrated sensor data, calibration information and reference analyte concentration values, pairing reference analyte concentration values with calibrated sensor data to form paired data, grouping paired data into calibration sets based on calibration sensitivity used for each paired data, computing one or more calibration error metrics for each calibration set, determining a correlation between the one or more calibration error metrics of the calibration sets and one or more measureable factors, determining a correction function that maps the determined correlation between the one or more calibration error metrics of the calibration sets and one or more measureable factors, computing a current sensitivity based on the reference analyte concentration value and the sensor data, applying a correction factor based on the correction function to the computed current sensitivity to determine a corrected sensitivity, and displaying an analyte level of a patient based on the sensor being calibrated using the corrected sensitivity.
In certain embodiments, the correction function is implemented as a look-up table.
In certain embodiments, the measureable factors include at least one of time of day of calibration, elapsed time since sensor start of calibration, and the ratio of calibration sensitivity to ideal sensitivity.
Certain embodiments may further comprise updating the correction function based on at least one of subsequently received sensor data, calibrated sensor data, calibration information and reference analyte concentration values.
Various other modifications and alterations in the structure and method of operation of the embodiments of the present disclosure will be apparent to those skilled in the art without departing from the scope and spirit of the present disclosure. Although the present disclosure has been described in connection with certain embodiments, it should be understood that the present disclosure as claimed should not be unduly limited to such embodiments. It is intended that the following claims define the scope of the present disclosure and that structures and methods within the scope of these claims and their equivalents be covered thereby.
The present application is a continuation of U.S. patent application Ser. No. 16/256,855 filed Jan. 24, 2019, which is a continuation of U.S. patent application Ser. No. 15/789,949 filed Oct. 20, 2017, now U.S. Pat. No. 10,188,334, which is a continuation of U.S. patent application Ser. No. 15/616,916 filed Jun. 7, 2017, now U.S. Pat. No. 9,801,577, which is a continuation of U.S. patent application Ser. No. 14/066,650 filed Oct. 29, 2013, now U.S. Pat. No. 9,675,290, which claims priority to U.S. Provisional Application No. 61/720,393 filed Oct. 30, 2012, entitled “Sensitivity Calibration of In Vivo Sensors Used to Measure Analyte Concentration”, the disclosure of which is incorporated herein by reference for all purposes.
| Number | Name | Date | Kind |
|---|---|---|---|
| 683553 | Carter | Oct 1901 | A |
| 3581062 | Aston | May 1971 | A |
| 3926760 | Allen et al. | Dec 1975 | A |
| 3949388 | Fuller | Apr 1976 | A |
| 3960497 | Acord et al. | Jun 1976 | A |
| 3978856 | Michel | Sep 1976 | A |
| 4036749 | Anderson | Jul 1977 | A |
| 4055175 | Clemens et al. | Oct 1977 | A |
| 4129128 | McFarlane | Dec 1978 | A |
| 4245634 | Albisser et al. | Jan 1981 | A |
| 4327725 | Cortese et al. | May 1982 | A |
| 4344438 | Schultz | Aug 1982 | A |
| 4349728 | Phillips et al. | Sep 1982 | A |
| 4373527 | Fischell | Feb 1983 | A |
| 4392849 | Petre et al. | Jul 1983 | A |
| 4425920 | Bourland et al. | Jan 1984 | A |
| 4441968 | Emmer et al. | Apr 1984 | A |
| 4462048 | Ross | Jul 1984 | A |
| 4478976 | Goertz et al. | Oct 1984 | A |
| 4494950 | Fischell | Jan 1985 | A |
| 4509531 | Ward | Apr 1985 | A |
| 4527240 | Kvitash | Jul 1985 | A |
| 4538616 | Rogoff | Sep 1985 | A |
| 4545382 | Higgins et al. | Oct 1985 | A |
| 4619793 | Lee | Oct 1986 | A |
| 4650547 | Gough | Mar 1987 | A |
| 4671288 | Gough | Jun 1987 | A |
| 4703756 | Gough et al. | Nov 1987 | A |
| 4711245 | Higgins et al. | Dec 1987 | A |
| 4731051 | Fischell | Mar 1988 | A |
| 4731726 | Allen, III | Mar 1988 | A |
| 4749985 | Corsberg | Jun 1988 | A |
| 4750496 | Reinhart et al. | Jun 1988 | A |
| 4757022 | Shults et al. | Jul 1988 | A |
| 4759366 | Callaghan | Jul 1988 | A |
| 4777953 | Ash et al. | Oct 1988 | A |
| 4779618 | Mund et al. | Oct 1988 | A |
| 4854322 | Ash et al. | Aug 1989 | A |
| 4871351 | Feingold | Oct 1989 | A |
| 4890620 | Gough | Jan 1990 | A |
| 4925268 | Iyer et al. | May 1990 | A |
| 4947845 | Davis | Aug 1990 | A |
| 4953552 | DeMarzo | Sep 1990 | A |
| 4986271 | Wilkins | Jan 1991 | A |
| 4995402 | Smith et al. | Feb 1991 | A |
| 5000180 | Kuypers et al. | Mar 1991 | A |
| 5002054 | Ash et al. | Mar 1991 | A |
| 5019974 | Beckers | May 1991 | A |
| 5034112 | Murase et al. | Jul 1991 | A |
| 5050612 | Matsumura | Sep 1991 | A |
| 5055171 | Peck | Oct 1991 | A |
| 5068536 | Rosenthal | Nov 1991 | A |
| 5077476 | Rosenthal | Dec 1991 | A |
| 5082550 | Rishpon et al. | Jan 1992 | A |
| 5089112 | Skotheim et al. | Feb 1992 | A |
| 5106365 | Hernandez | Apr 1992 | A |
| 5113869 | Nappholz et al. | May 1992 | A |
| 5122925 | Inpyn | Jun 1992 | A |
| 5135004 | Adams et al. | Aug 1992 | A |
| 5145381 | Volz | Sep 1992 | A |
| 5148812 | Verrier et al. | Sep 1992 | A |
| 5165407 | Wilson et al. | Nov 1992 | A |
| 5199428 | Obel et al. | Apr 1993 | A |
| 5202261 | Musho et al. | Apr 1993 | A |
| 5203326 | Collins | Apr 1993 | A |
| 5204264 | Kaminer et al. | Apr 1993 | A |
| 5210778 | Massart | May 1993 | A |
| 5231988 | Wernicke et al. | Aug 1993 | A |
| 5246867 | Lakowicz et al. | Sep 1993 | A |
| 5262035 | Gregg et al. | Nov 1993 | A |
| 5262305 | Heller et al. | Nov 1993 | A |
| 5264103 | Yoshioka et al. | Nov 1993 | A |
| 5264104 | Gregg et al. | Nov 1993 | A |
| 5264105 | Gregg et al. | Nov 1993 | A |
| 5279294 | Anderson et al. | Jan 1994 | A |
| 5285792 | Sjoquist et al. | Feb 1994 | A |
| 5293877 | O'Hara et al. | Mar 1994 | A |
| 5299571 | Mastrototaro | Apr 1994 | A |
| 5313953 | Yomtov et al. | May 1994 | A |
| 5320715 | Berg | Jun 1994 | A |
| 5320725 | Gregg et al. | Jun 1994 | A |
| 5322063 | Allen et al. | Jun 1994 | A |
| 5328460 | Lord et al. | Jul 1994 | A |
| 5330634 | Wong et al. | Jul 1994 | A |
| 5340722 | Wolfbeis et al. | Aug 1994 | A |
| 5342789 | Chick et al. | Aug 1994 | A |
| 5352351 | White et al. | Oct 1994 | A |
| 5354449 | Band et al. | Oct 1994 | A |
| 5356786 | Heller et al. | Oct 1994 | A |
| 5360404 | Novacek et al. | Nov 1994 | A |
| 5365426 | Siegel et al. | Nov 1994 | A |
| 5372427 | Padovani et al. | Dec 1994 | A |
| 5376070 | Purvis et al. | Dec 1994 | A |
| 5379238 | Stark | Jan 1995 | A |
| 5384547 | Lynk et al. | Jan 1995 | A |
| 5390671 | Lord et al. | Feb 1995 | A |
| 5391250 | Cheney, II et al. | Feb 1995 | A |
| 5400795 | Murphy et al. | Mar 1995 | A |
| 5408999 | Singh et al. | Apr 1995 | A |
| 5411647 | Johnson et al. | May 1995 | A |
| 5425749 | Adams | Jun 1995 | A |
| 5425868 | Pedersen | Jun 1995 | A |
| 5431160 | Wilkins | Jul 1995 | A |
| 5431921 | Thombre | Jul 1995 | A |
| 5438983 | Falcone | Aug 1995 | A |
| 5462645 | Albery et al. | Oct 1995 | A |
| 5472317 | Field et al. | Dec 1995 | A |
| 5489414 | Schreiber et al. | Feb 1996 | A |
| 5497772 | Schulman et al. | Mar 1996 | A |
| 5505828 | Wong et al. | Apr 1996 | A |
| 5507288 | Bocker et al. | Apr 1996 | A |
| 5509410 | Hill et al. | Apr 1996 | A |
| 5514718 | Lewis et al. | May 1996 | A |
| 5520191 | Karlsson et al. | May 1996 | A |
| 5531878 | Vadgama et al. | Jul 1996 | A |
| 5532686 | Urbas et al. | Jul 1996 | A |
| 5543326 | Heller et al. | Aug 1996 | A |
| 5552997 | Massart | Sep 1996 | A |
| 5568400 | Stark et al. | Oct 1996 | A |
| 5568806 | Cheney, II et al. | Oct 1996 | A |
| 5569186 | Lord et al. | Oct 1996 | A |
| 5582184 | Erickson et al. | Dec 1996 | A |
| 5586553 | Halili et al. | Dec 1996 | A |
| 5593852 | Heller et al. | Jan 1997 | A |
| 5601435 | Quy | Feb 1997 | A |
| 5609575 | Larson et al. | Mar 1997 | A |
| 5628310 | Rao et al. | May 1997 | A |
| 5628890 | Carter et al. | May 1997 | A |
| 5634468 | Platt et al. | Jun 1997 | A |
| 5640954 | Pfeiffer et al. | Jun 1997 | A |
| 5653239 | Pompei et al. | Aug 1997 | A |
| 5660163 | Schulman et al. | Aug 1997 | A |
| 5665222 | Heller et al. | Sep 1997 | A |
| 5695623 | Michel et al. | Dec 1997 | A |
| 5707502 | McCaffrey et al. | Jan 1998 | A |
| 5711001 | Bussan et al. | Jan 1998 | A |
| 5711861 | Ward et al. | Jan 1998 | A |
| 5720295 | Greenhut et al. | Feb 1998 | A |
| 5724030 | Urbas et al. | Mar 1998 | A |
| 5733259 | Valcke et al. | Mar 1998 | A |
| 5735285 | Albert et al. | Apr 1998 | A |
| 5741211 | Renirie et al. | Apr 1998 | A |
| 5749907 | Mann | May 1998 | A |
| 5772586 | Heinonen et al. | Jun 1998 | A |
| 5785660 | van Lake et al. | Jul 1998 | A |
| 5786439 | Van Antwerp et al. | Jul 1998 | A |
| 5791344 | Schulman et al. | Aug 1998 | A |
| 5792065 | Xue et al. | Aug 1998 | A |
| 5804047 | Karube et al. | Sep 1998 | A |
| 5820551 | Hill et al. | Oct 1998 | A |
| 5822715 | Worthington et al. | Oct 1998 | A |
| 5863400 | Drummond et al. | Jan 1999 | A |
| 5891047 | Lander et al. | Apr 1999 | A |
| 5891049 | Cyrus et al. | Apr 1999 | A |
| 5899855 | Brown | May 1999 | A |
| 5914026 | Blubaugh, Jr. et al. | Jun 1999 | A |
| 5918603 | Brown | Jul 1999 | A |
| 5925021 | Castellano et al. | Jul 1999 | A |
| 5935224 | Svancarek et al. | Aug 1999 | A |
| 5942979 | Luppino | Aug 1999 | A |
| 5951485 | Cyrus et al. | Sep 1999 | A |
| 5957854 | Besson et al. | Sep 1999 | A |
| 5960797 | Kramer et al. | Oct 1999 | A |
| 5961451 | Reber et al. | Oct 1999 | A |
| 5964993 | Blubaugh, Jr. et al. | Oct 1999 | A |
| 5965380 | Heller et al. | Oct 1999 | A |
| 5971922 | Arita et al. | Oct 1999 | A |
| 5995860 | Sun et al. | Nov 1999 | A |
| 6001067 | Shults et al. | Dec 1999 | A |
| 6016443 | Ekwall et al. | Jan 2000 | A |
| 6021350 | Mathson | Feb 2000 | A |
| 6024699 | Surwit et al. | Feb 2000 | A |
| 6038469 | Karlsson et al. | Mar 2000 | A |
| 6049727 | Crothall | Apr 2000 | A |
| 6071391 | Gotoh et al. | Jun 2000 | A |
| 6073031 | Helstab et al. | Jun 2000 | A |
| 6083710 | Heller et al. | Jul 2000 | A |
| 6088608 | Schulman et al. | Jul 2000 | A |
| 6091976 | Pfeiffer et al. | Jul 2000 | A |
| 6091987 | Thompson | Jul 2000 | A |
| 6093172 | Funderburk et al. | Jul 2000 | A |
| 6103033 | Say et al. | Aug 2000 | A |
| 6108577 | Benser | Aug 2000 | A |
| 6112116 | Fischell | Aug 2000 | A |
| 6115622 | Minoz | Sep 2000 | A |
| 6115628 | Stadler et al. | Sep 2000 | A |
| 6117290 | Say et al. | Sep 2000 | A |
| 6119028 | Schulman et al. | Sep 2000 | A |
| 6120676 | Heller et al. | Sep 2000 | A |
| 6121009 | Heller et al. | Sep 2000 | A |
| 6121611 | Lindsay et al. | Sep 2000 | A |
| 6122351 | Schlueter, Jr. et al. | Sep 2000 | A |
| 6128526 | Stadler et al. | Oct 2000 | A |
| 6130623 | MacLellan et al. | Oct 2000 | A |
| 6134461 | Say et al. | Oct 2000 | A |
| 6143164 | Heller et al. | Nov 2000 | A |
| 6144837 | Quy | Nov 2000 | A |
| 6144871 | Saito et al. | Nov 2000 | A |
| 6159147 | Lichter et al. | Dec 2000 | A |
| 6161095 | Brown | Dec 2000 | A |
| 6162611 | Heller et al. | Dec 2000 | A |
| 6168957 | Matzinger et al. | Jan 2001 | B1 |
| 6175752 | Say et al. | Jan 2001 | B1 |
| 6200265 | Walsh et al. | Mar 2001 | B1 |
| 6212416 | Ward et al. | Apr 2001 | B1 |
| 6212417 | Ikeda et al. | Apr 2001 | B1 |
| 6219574 | Cormier et al. | Apr 2001 | B1 |
| 6223283 | Chaiken et al. | Apr 2001 | B1 |
| 6233471 | Berner et al. | May 2001 | B1 |
| 6233486 | Ekwall et al. | May 2001 | B1 |
| 6237394 | Harris et al. | May 2001 | B1 |
| 6248067 | Causey, III et al. | Jun 2001 | B1 |
| 6249705 | Snell | Jun 2001 | B1 |
| 6254586 | Mann et al. | Jul 2001 | B1 |
| 6256538 | Ekwall | Jul 2001 | B1 |
| 6264606 | Ekwall et al. | Jul 2001 | B1 |
| 6270455 | Brown | Aug 2001 | B1 |
| 6272379 | Fischell et al. | Aug 2001 | B1 |
| 6275717 | Gross et al. | Aug 2001 | B1 |
| 6283761 | Joao | Sep 2001 | B1 |
| 6284478 | Heller et al. | Sep 2001 | B1 |
| 6291200 | LeJeune et al. | Sep 2001 | B1 |
| 6293925 | Safabash et al. | Sep 2001 | B1 |
| 6294997 | Paratore et al. | Sep 2001 | B1 |
| 6295506 | Heinonen et al. | Sep 2001 | B1 |
| 6299757 | Feldman et al. | Oct 2001 | B1 |
| 6306104 | Cunningham et al. | Oct 2001 | B1 |
| 6309884 | Cooper et al. | Oct 2001 | B1 |
| 6329161 | Heller et al. | Dec 2001 | B1 |
| 6338790 | Feldman et al. | Jan 2002 | B1 |
| 6348640 | Navot et al. | Feb 2002 | B1 |
| 6359444 | Grimes | Mar 2002 | B1 |
| 6360888 | McIvor et al. | Mar 2002 | B1 |
| 6361503 | Starobin et al. | Mar 2002 | B1 |
| 6366794 | Moussy et al. | Apr 2002 | B1 |
| 6368141 | VanAntwerp et al. | Apr 2002 | B1 |
| 6377828 | Chaiken et al. | Apr 2002 | B1 |
| 6377852 | Bornzin et al. | Apr 2002 | B1 |
| 6377894 | Deweese et al. | Apr 2002 | B1 |
| 6379301 | Worthington et al. | Apr 2002 | B1 |
| 6381493 | Stadler et al. | Apr 2002 | B1 |
| 6387048 | Schulman et al. | May 2002 | B1 |
| 6400974 | Lesho | Jun 2002 | B1 |
| 6405066 | Essenpreis et al. | Jun 2002 | B1 |
| 6413393 | Van Antwerp et al. | Jul 2002 | B1 |
| 6416471 | Kumar et al. | Jul 2002 | B1 |
| 6418346 | Nelson et al. | Jul 2002 | B1 |
| 6424847 | Mastrototaro et al. | Jul 2002 | B1 |
| 6427088 | Bowman, IV et al. | Jul 2002 | B1 |
| 6440068 | Brown et al. | Aug 2002 | B1 |
| 6461496 | Feldman et al. | Oct 2002 | B1 |
| 6471689 | Joseph et al. | Oct 2002 | B1 |
| 6475372 | Ohara et al. | Nov 2002 | B1 |
| 6475750 | Han et al. | Nov 2002 | B1 |
| 6478736 | Mault | Nov 2002 | B1 |
| 6484046 | Say et al. | Nov 2002 | B1 |
| 6496729 | Thompson | Dec 2002 | B2 |
| 6497655 | Linberg et al. | Dec 2002 | B1 |
| 6501983 | Natarajan et al. | Dec 2002 | B1 |
| 6503381 | Gotoh et al. | Jan 2003 | B1 |
| 6514460 | Fendrock | Feb 2003 | B1 |
| 6514718 | Heller et al. | Feb 2003 | B2 |
| 6520326 | McIvor et al. | Feb 2003 | B2 |
| 6522903 | Berman et al. | Feb 2003 | B1 |
| 6540891 | Stewart et al. | Apr 2003 | B1 |
| 6544212 | Galley et al. | Apr 2003 | B2 |
| 6549796 | Sohrab | Apr 2003 | B2 |
| 6551494 | Heller et al. | Apr 2003 | B1 |
| 6558320 | Causey, III et al. | May 2003 | B1 |
| 6558321 | Burd et al. | May 2003 | B1 |
| 6558351 | Steil et al. | May 2003 | B1 |
| 6560471 | Heller et al. | May 2003 | B1 |
| 6561975 | Pool et al. | May 2003 | B1 |
| 6561978 | Conn et al. | May 2003 | B1 |
| 6562001 | Lebel et al. | May 2003 | B2 |
| 6564105 | Starkweather et al. | May 2003 | B2 |
| 6565509 | Say et al. | May 2003 | B1 |
| 6571128 | Lebel et al. | May 2003 | B2 |
| 6572542 | Houben et al. | Jun 2003 | B1 |
| 6574490 | Abbink et al. | Jun 2003 | B2 |
| 6574510 | Von Arx et al. | Jun 2003 | B2 |
| 6576101 | Heller et al. | Jun 2003 | B1 |
| 6577899 | Lebel et al. | Jun 2003 | B2 |
| 6579231 | Phipps | Jun 2003 | B1 |
| 6579690 | Bonnecaze et al. | Jun 2003 | B1 |
| 6585644 | Lebel et al. | Jul 2003 | B2 |
| 6587704 | Fine et al. | Jul 2003 | B1 |
| 6591125 | Buse et al. | Jul 2003 | B1 |
| 6592745 | Feldman et al. | Jul 2003 | B1 |
| 6595919 | Berner et al. | Jul 2003 | B2 |
| 6600997 | Deweese et al. | Jul 2003 | B2 |
| 6605200 | Mao et al. | Aug 2003 | B1 |
| 6605201 | Mao et al. | Aug 2003 | B1 |
| 6607509 | Bobroff et al. | Aug 2003 | B2 |
| 6610012 | Mault | Aug 2003 | B2 |
| 6616819 | Liamos et al. | Sep 2003 | B1 |
| 6618934 | Feldman et al. | Sep 2003 | B1 |
| 6622045 | Snell et al. | Sep 2003 | B2 |
| 6633772 | Ford et al. | Oct 2003 | B2 |
| 6635014 | Starkweather et al. | Oct 2003 | B2 |
| 6635167 | Batman et al. | Oct 2003 | B1 |
| 6641533 | Causey, III et al. | Nov 2003 | B2 |
| 6648821 | Lebel et al. | Nov 2003 | B2 |
| 6650471 | Doi | Nov 2003 | B2 |
| 6654625 | Say et al. | Nov 2003 | B1 |
| 6656114 | Poulson et al. | Dec 2003 | B1 |
| 6658396 | Tang et al. | Dec 2003 | B1 |
| 6659948 | Lebel et al. | Dec 2003 | B2 |
| 6668196 | Villegas et al. | Dec 2003 | B1 |
| 6675030 | Ciuczak et al. | Jan 2004 | B2 |
| 6676816 | Mao et al. | Jan 2004 | B2 |
| 6687546 | Lebel et al. | Feb 2004 | B2 |
| 6689056 | Kilcoyne et al. | Feb 2004 | B1 |
| 6694191 | Starkweather et al. | Feb 2004 | B2 |
| 6695860 | Ward et al. | Feb 2004 | B1 |
| 6698269 | Baber et al. | Mar 2004 | B2 |
| 6702857 | Brauker et al. | Mar 2004 | B2 |
| 6721582 | Trepagnier et al. | Apr 2004 | B2 |
| 6730200 | Stewart et al. | May 2004 | B1 |
| 6731976 | Penn et al. | May 2004 | B2 |
| 6731985 | Poore et al. | May 2004 | B2 |
| 6733446 | Lebel et al. | May 2004 | B2 |
| 6735183 | O'Toole et al. | May 2004 | B2 |
| 6736957 | Forrow et al. | May 2004 | B1 |
| 6740075 | Lebel et al. | May 2004 | B2 |
| 6741877 | Shults et al. | May 2004 | B1 |
| 6746582 | Heller et al. | Jun 2004 | B2 |
| 6749740 | Liamos et al. | Jun 2004 | B2 |
| 6758810 | Lebel et al. | Jul 2004 | B2 |
| 6764581 | Forrow et al. | Jul 2004 | B1 |
| 6770030 | Schaupp et al. | Aug 2004 | B1 |
| 6773671 | Lewis et al. | Aug 2004 | B1 |
| 6790178 | Mault et al. | Sep 2004 | B1 |
| 6804558 | Haller et al. | Oct 2004 | B2 |
| 6809653 | Mann et al. | Oct 2004 | B1 |
| 6810290 | Lebel et al. | Oct 2004 | B2 |
| 6811533 | Lebel et al. | Nov 2004 | B2 |
| 6811534 | Bowman, IV et al. | Nov 2004 | B2 |
| 6813519 | Lebel et al. | Nov 2004 | B2 |
| 6850790 | Berner et al. | Feb 2005 | B2 |
| 6850859 | Schuh | Feb 2005 | B1 |
| 6862465 | Shults et al. | Mar 2005 | B2 |
| 6865407 | Kimball et al. | Mar 2005 | B2 |
| 6873268 | Lebel et al. | Mar 2005 | B2 |
| 6878112 | Linberg et al. | Apr 2005 | B2 |
| 6881551 | Heller et al. | Apr 2005 | B2 |
| 6882940 | Potts et al. | Apr 2005 | B2 |
| 6892085 | McIvor et al. | May 2005 | B2 |
| 6893545 | Gotoh et al. | May 2005 | B2 |
| 6895263 | Shin et al. | May 2005 | B2 |
| 6895265 | Silver | May 2005 | B2 |
| 6912413 | Rantala et al. | Jun 2005 | B2 |
| 6923763 | Kovatchev et al. | Aug 2005 | B1 |
| 6923764 | Aceti et al. | Aug 2005 | B2 |
| 6931327 | Goode, Jr. et al. | Aug 2005 | B2 |
| 6932892 | Chen et al. | Aug 2005 | B2 |
| 6932894 | Mao et al. | Aug 2005 | B2 |
| 6936006 | Sabra | Aug 2005 | B2 |
| 6940403 | Kail, IV | Sep 2005 | B2 |
| 6941163 | Ford et al. | Sep 2005 | B2 |
| 6942518 | Liamos et al. | Sep 2005 | B2 |
| 6950708 | Bowman, IV et al. | Sep 2005 | B2 |
| 6954662 | Freger et al. | Oct 2005 | B2 |
| 6958705 | Lebel et al. | Oct 2005 | B2 |
| 6968294 | Gutta et al. | Nov 2005 | B2 |
| 6971274 | Olin | Dec 2005 | B2 |
| 6974437 | Lebel et al. | Dec 2005 | B2 |
| 6990366 | Say et al. | Jan 2006 | B2 |
| 6997907 | Safabash et al. | Feb 2006 | B2 |
| 6998247 | Monfre et al. | Feb 2006 | B2 |
| 7003336 | Holker et al. | Feb 2006 | B2 |
| 7003340 | Say et al. | Feb 2006 | B2 |
| 7003341 | Say et al. | Feb 2006 | B2 |
| 7009511 | Mazar et al. | Mar 2006 | B2 |
| 7010345 | Hill et al. | Mar 2006 | B2 |
| 7011630 | Desai et al. | Mar 2006 | B2 |
| 7016713 | Gardner et al. | Mar 2006 | B2 |
| 7016720 | Kroll | Mar 2006 | B2 |
| 7020508 | Stivoric et al. | Mar 2006 | B2 |
| 7022072 | Fox et al. | Apr 2006 | B2 |
| 7022219 | Mansouri et al. | Apr 2006 | B2 |
| 7024236 | Ford et al. | Apr 2006 | B2 |
| 7024245 | Lebel et al. | Apr 2006 | B2 |
| 7025425 | Kovatchev et al. | Apr 2006 | B2 |
| 7029443 | Kroll | Apr 2006 | B2 |
| 7029444 | Shin et al. | Apr 2006 | B2 |
| 7041068 | Freeman et al. | May 2006 | B2 |
| 7041468 | Drucker et al. | May 2006 | B2 |
| 7043287 | Khalil et al. | May 2006 | B1 |
| 7043305 | KenKnight et al. | May 2006 | B2 |
| 7052472 | Miller et al. | May 2006 | B1 |
| 7052483 | Wojcik | May 2006 | B2 |
| 7056302 | Douglas | Jun 2006 | B2 |
| 7058453 | Nelson et al. | Jun 2006 | B2 |
| 7060031 | Webb et al. | Jun 2006 | B2 |
| 7074307 | Simpson et al. | Jul 2006 | B2 |
| 7076300 | Kroll et al. | Jul 2006 | B1 |
| 7081195 | Simpson et al. | Jul 2006 | B2 |
| 7082334 | Boute et al. | Jul 2006 | B2 |
| 7092891 | Maus et al. | Aug 2006 | B2 |
| 7096064 | Deno et al. | Aug 2006 | B2 |
| 7098803 | Mann et al. | Aug 2006 | B2 |
| 7103412 | Kroll | Sep 2006 | B1 |
| 7108778 | Simpson et al. | Sep 2006 | B2 |
| 7110803 | Shults et al. | Sep 2006 | B2 |
| 7113821 | Sun et al. | Sep 2006 | B1 |
| 7118667 | Lee | Oct 2006 | B2 |
| 7123950 | Mannheimer | Oct 2006 | B2 |
| 7125382 | Zhou et al. | Oct 2006 | B2 |
| 7134999 | Brauker et al. | Nov 2006 | B2 |
| 7136689 | Shults et al. | Nov 2006 | B2 |
| 7142911 | Boileau et al. | Nov 2006 | B2 |
| 7153265 | Vachon | Dec 2006 | B2 |
| 7167818 | Brown | Jan 2007 | B2 |
| 7171274 | Starkweather et al. | Jan 2007 | B2 |
| 7183102 | Monfre et al. | Feb 2007 | B2 |
| 7190988 | Say et al. | Mar 2007 | B2 |
| 7192450 | Brauker et al. | Mar 2007 | B2 |
| 7198606 | Boecker et al. | Apr 2007 | B2 |
| 7203549 | Schommer et al. | Apr 2007 | B2 |
| 7220387 | Flaherty et al. | May 2007 | B2 |
| 7225535 | Feldman et al. | Jun 2007 | B2 |
| 7226978 | Tapsak et al. | Jun 2007 | B2 |
| 7228182 | Healy et al. | Jun 2007 | B2 |
| 7237712 | DeRocco et al. | Jul 2007 | B2 |
| 7258673 | Racchini et al. | Aug 2007 | B2 |
| 7267665 | Steil et al. | Sep 2007 | B2 |
| 7272436 | Gill et al. | Sep 2007 | B2 |
| 7276029 | Goode, Jr. et al. | Oct 2007 | B2 |
| 7278983 | Ireland et al. | Oct 2007 | B2 |
| 7295867 | Berner et al. | Nov 2007 | B2 |
| 7297114 | Gill et al. | Nov 2007 | B2 |
| 7299082 | Feldman et al. | Nov 2007 | B2 |
| 7310544 | Brister et al. | Dec 2007 | B2 |
| 7317938 | Lorenz et al. | Jan 2008 | B2 |
| 7318816 | Bobroff et al. | Jan 2008 | B2 |
| 7324850 | Persen et al. | Jan 2008 | B2 |
| 7335294 | Heller et al. | Feb 2008 | B2 |
| 7347819 | Lebel et al. | Mar 2008 | B2 |
| 7354420 | Steil et al. | Apr 2008 | B2 |
| 7364592 | Carr-Brendel et al. | Apr 2008 | B2 |
| 7366556 | Brister et al. | Apr 2008 | B2 |
| 7379765 | Petisce et al. | May 2008 | B2 |
| 7384397 | Zhang et al. | Jun 2008 | B2 |
| 7387010 | Sunshine et al. | Jun 2008 | B2 |
| 7399277 | Saidara et al. | Jul 2008 | B2 |
| 7402153 | Steil et al. | Jul 2008 | B2 |
| 7419573 | Gundel | Sep 2008 | B2 |
| 7424318 | Brister et al. | Sep 2008 | B2 |
| 7460898 | Brister et al. | Dec 2008 | B2 |
| 7467003 | Brister et al. | Dec 2008 | B2 |
| 7468125 | Kraft et al. | Dec 2008 | B2 |
| 7471972 | Rhodes et al. | Dec 2008 | B2 |
| 7474992 | Ariyur | Jan 2009 | B2 |
| 7491303 | Sakata et al. | Feb 2009 | B2 |
| 7492254 | Bandy et al. | Feb 2009 | B2 |
| 7494465 | Brister et al. | Feb 2009 | B2 |
| 7497827 | Brister et al. | Mar 2009 | B2 |
| 7499002 | Blasko et al. | Mar 2009 | B2 |
| 7502644 | Gill et al. | Mar 2009 | B2 |
| 7519408 | Rasdal et al. | Apr 2009 | B2 |
| 7519478 | Bartkowiak et al. | Apr 2009 | B2 |
| 7523004 | Bartkowiak et al. | Apr 2009 | B2 |
| 7524287 | Bharmi | Apr 2009 | B2 |
| 7547281 | Hayes et al. | Jun 2009 | B2 |
| 7565197 | Haubrich et al. | Jul 2009 | B2 |
| 7569030 | Lebel et al. | Aug 2009 | B2 |
| 7574266 | Dudding et al. | Aug 2009 | B2 |
| 7577469 | Aronowitz et al. | Aug 2009 | B1 |
| 7583990 | Goode, Jr. et al. | Sep 2009 | B2 |
| 7591801 | Brauker et al. | Sep 2009 | B2 |
| 7599726 | Goode, Jr. et al. | Oct 2009 | B2 |
| 7602310 | Mann et al. | Oct 2009 | B2 |
| 7604178 | Stewart | Oct 2009 | B2 |
| 7613491 | Boock et al. | Nov 2009 | B2 |
| 7615007 | Shults et al. | Nov 2009 | B2 |
| 7618369 | Hayter et al. | Nov 2009 | B2 |
| 7620438 | He | Nov 2009 | B2 |
| 7630748 | Budiman | Dec 2009 | B2 |
| 7632228 | Brauker et al. | Dec 2009 | B2 |
| 7635594 | Holmes et al. | Dec 2009 | B2 |
| 7637868 | Saint et al. | Dec 2009 | B2 |
| 7640048 | Dobbles et al. | Dec 2009 | B2 |
| 7659823 | Killian et al. | Feb 2010 | B1 |
| 7668596 | Von Arx et al. | Feb 2010 | B2 |
| 7699775 | Desai et al. | Apr 2010 | B2 |
| 7699964 | Feldman et al. | Apr 2010 | B2 |
| 7711493 | Bartkowiak et al. | May 2010 | B2 |
| 7736310 | Taub et al. | Jun 2010 | B2 |
| 7741734 | Joannopoulos et al. | Jun 2010 | B2 |
| 7751864 | Buck, Jr. | Jul 2010 | B2 |
| 7766829 | Sloan et al. | Aug 2010 | B2 |
| 7771352 | Shults et al. | Aug 2010 | B2 |
| 7774145 | Bruaker et al. | Aug 2010 | B2 |
| 7778680 | Goode, Jr. et al. | Aug 2010 | B2 |
| 7779332 | Karr et al. | Aug 2010 | B2 |
| 7782192 | Jeckelmann et al. | Aug 2010 | B2 |
| 7783333 | Brister et al. | Aug 2010 | B2 |
| 7791467 | Mazar et al. | Sep 2010 | B2 |
| 7792562 | Shults et al. | Sep 2010 | B2 |
| 7826981 | Goode, Jr. et al. | Nov 2010 | B2 |
| 7831310 | Lebel et al. | Nov 2010 | B2 |
| 7842174 | Zhou et al. | Nov 2010 | B2 |
| 7857760 | Brister et al. | Dec 2010 | B2 |
| 7860574 | Von Arx et al. | Dec 2010 | B2 |
| 7866026 | Wang et al. | Jan 2011 | B1 |
| 7882611 | Shah et al. | Feb 2011 | B2 |
| 7885697 | Brister et al. | Feb 2011 | B2 |
| 7889069 | Fifolt et al. | Feb 2011 | B2 |
| 7899511 | Shults et al. | Mar 2011 | B2 |
| 7905833 | Brister et al. | Mar 2011 | B2 |
| 7912674 | Killoren Clark et al. | Mar 2011 | B2 |
| 7914450 | Goode, Jr. et al. | Mar 2011 | B2 |
| 7916013 | Stevenson | Mar 2011 | B2 |
| 7920906 | Goode et al. | Apr 2011 | B2 |
| 7938797 | Estes | May 2011 | B2 |
| 7946984 | Brister et al. | May 2011 | B2 |
| 7955258 | Goscha et al. | Jun 2011 | B2 |
| 7970448 | Shults et al. | Jun 2011 | B2 |
| 7974672 | Shults et al. | Jul 2011 | B2 |
| 7999674 | Kamen | Aug 2011 | B2 |
| 8060173 | Goode, Jr. et al. | Nov 2011 | B2 |
| 8072310 | Everhart | Dec 2011 | B1 |
| 8090445 | Ginggen | Jan 2012 | B2 |
| 8093991 | Stevenson et al. | Jan 2012 | B2 |
| 8094009 | Allen et al. | Jan 2012 | B2 |
| 8098159 | Batra et al. | Jan 2012 | B2 |
| 8098160 | Howarth et al. | Jan 2012 | B2 |
| 8098161 | Lavedas | Jan 2012 | B2 |
| 8098201 | Choi et al. | Jan 2012 | B2 |
| 8098208 | Ficker et al. | Jan 2012 | B2 |
| 8102021 | Degani | Jan 2012 | B2 |
| 8102154 | Bishop et al. | Jan 2012 | B2 |
| 8102263 | Yeo et al. | Jan 2012 | B2 |
| 8102789 | Rosar et al. | Jan 2012 | B2 |
| 8103241 | Young et al. | Jan 2012 | B2 |
| 8103325 | Swedlow et al. | Jan 2012 | B2 |
| 8111042 | Bennett | Feb 2012 | B2 |
| 8115488 | McDowell | Feb 2012 | B2 |
| 8116681 | Baarman | Feb 2012 | B2 |
| 8116683 | Baarman | Feb 2012 | B2 |
| 8116837 | Huang | Feb 2012 | B2 |
| 8117481 | Anselmi et al. | Feb 2012 | B2 |
| 8120493 | Burr | Feb 2012 | B2 |
| 8124452 | Sheats | Feb 2012 | B2 |
| 8130093 | Mazar et al. | Mar 2012 | B2 |
| 8131351 | Kalgren et al. | Mar 2012 | B2 |
| 8131365 | Zhang et al. | Mar 2012 | B2 |
| 8131565 | Dicks et al. | Mar 2012 | B2 |
| 8132037 | Fehr et al. | Mar 2012 | B2 |
| 8135352 | Langsweirdt et al. | Mar 2012 | B2 |
| 8136735 | Arai et al. | Mar 2012 | B2 |
| 8138925 | Downie et al. | Mar 2012 | B2 |
| 8140160 | Pless et al. | Mar 2012 | B2 |
| 8140168 | Olson et al. | Mar 2012 | B2 |
| 8140299 | Siess | Mar 2012 | B2 |
| 8140312 | Hayter et al. | Mar 2012 | B2 |
| 8150321 | Winter et al. | Apr 2012 | B2 |
| 8150516 | Levine et al. | Apr 2012 | B2 |
| 8160900 | Taub et al. | Apr 2012 | B2 |
| 8170803 | Kamath et al. | May 2012 | B2 |
| 8179266 | Hermle | May 2012 | B2 |
| 8211016 | Budiman | Jul 2012 | B2 |
| 8216137 | Budiman | Jul 2012 | B2 |
| 8216138 | McGarraugh et al. | Jul 2012 | B1 |
| 8224415 | Budiman et al. | Jul 2012 | B2 |
| 8239166 | Hayter et al. | Aug 2012 | B2 |
| 8255026 | Al-Ali | Aug 2012 | B1 |
| 8282549 | Brauker et al. | Oct 2012 | B2 |
| 8376945 | Hayter et al. | Feb 2013 | B2 |
| 8396670 | St-Pierre | Mar 2013 | B2 |
| 8444560 | Hayter et al. | May 2013 | B2 |
| 8457703 | Al-Ali | Jun 2013 | B2 |
| 8484005 | Hayter et al. | Jul 2013 | B2 |
| 8532935 | Budiman | Sep 2013 | B2 |
| 8543354 | Luo et al. | Sep 2013 | B2 |
| 8571808 | Hayter | Oct 2013 | B2 |
| 8608923 | Zhou et al. | Dec 2013 | B2 |
| 8612163 | Hayter et al. | Dec 2013 | B2 |
| 8657746 | Roy | Feb 2014 | B2 |
| 8682615 | Hayter et al. | Mar 2014 | B2 |
| 9060719 | Hayter et al. | Jun 2015 | B2 |
| 9113828 | Budiman | Aug 2015 | B2 |
| 9241631 | Valdes et al. | Jan 2016 | B2 |
| 9398872 | Hayter et al. | Jul 2016 | B2 |
| 9408566 | Hayter et al. | Aug 2016 | B2 |
| 9483608 | Hayter et al. | Nov 2016 | B2 |
| 9504471 | Lee et al. | Nov 2016 | B2 |
| 9558325 | Hayter et al. | Jan 2017 | B2 |
| 9801577 | Budiman et al. | Oct 2017 | B2 |
| 9808574 | Yodfat et al. | Nov 2017 | B2 |
| 10820842 | Harper | Nov 2020 | B2 |
| 10827954 | Hoss et al. | Nov 2020 | B2 |
| 10874338 | Stafford | Dec 2020 | B2 |
| 10881341 | Curry et al. | Jan 2021 | B1 |
| 10945647 | Mazza | Mar 2021 | B2 |
| 10945649 | Lee et al. | Mar 2021 | B2 |
| 10952653 | Harper | Mar 2021 | B2 |
| 10959654 | Curry et al. | Mar 2021 | B2 |
| 10966644 | Stafford | Apr 2021 | B2 |
| 10973443 | Funderburk et al. | Apr 2021 | B2 |
| 11000213 | Kamath et al. | May 2021 | B2 |
| 11000216 | Curry et al. | May 2021 | B2 |
| 11013440 | Lee et al. | May 2021 | B2 |
| 11020031 | Simpson et al. | Jun 2021 | B1 |
| 11064917 | Simpson et al. | Jul 2021 | B2 |
| 11141084 | Funderburk et al. | Oct 2021 | B2 |
| 20010041831 | Starkweather et al. | Nov 2001 | A1 |
| 20020010390 | Guice et al. | Jan 2002 | A1 |
| 20020016534 | Trepagnier et al. | Feb 2002 | A1 |
| 20020019022 | Dunn et al. | Feb 2002 | A1 |
| 20020042090 | Heller et al. | Apr 2002 | A1 |
| 20020043651 | Darrow et al. | Apr 2002 | A1 |
| 20020065454 | Lebel et al. | May 2002 | A1 |
| 20020068860 | Clark | Jun 2002 | A1 |
| 20020072784 | Sheppard et al. | Jun 2002 | A1 |
| 20020103499 | Perez et al. | Aug 2002 | A1 |
| 20020106709 | Potts et al. | Aug 2002 | A1 |
| 20020120186 | Keimel | Aug 2002 | A1 |
| 20020128594 | Das et al. | Sep 2002 | A1 |
| 20020143266 | Bock | Oct 2002 | A1 |
| 20020143372 | Snell et al. | Oct 2002 | A1 |
| 20020156355 | Gough | Oct 2002 | A1 |
| 20020161288 | Shin et al. | Oct 2002 | A1 |
| 20020169635 | Shillingburg | Nov 2002 | A1 |
| 20020177764 | Sohrab | Nov 2002 | A1 |
| 20020193679 | Malave et al. | Dec 2002 | A1 |
| 20030003524 | Taniike et al. | Jan 2003 | A1 |
| 20030004403 | Drinan et al. | Jan 2003 | A1 |
| 20030023317 | Brauker et al. | Jan 2003 | A1 |
| 20030023461 | Quintanilla et al. | Jan 2003 | A1 |
| 20030032867 | Crothall et al. | Feb 2003 | A1 |
| 20030032874 | Rhodes et al. | Feb 2003 | A1 |
| 20030042137 | Mao et al. | Mar 2003 | A1 |
| 20030050546 | Desai et al. | Mar 2003 | A1 |
| 20030054428 | Monfre et al. | Mar 2003 | A1 |
| 20030065308 | Lebel et al. | Apr 2003 | A1 |
| 20030076082 | Morgan et al. | Apr 2003 | A1 |
| 20030100821 | Heller et al. | May 2003 | A1 |
| 20030125612 | Fox et al. | Jul 2003 | A1 |
| 20030130616 | Steil et al. | Jul 2003 | A1 |
| 20030134347 | Heller et al. | Jul 2003 | A1 |
| 20030168338 | Gao et al. | Sep 2003 | A1 |
| 20030176933 | Lebel et al. | Sep 2003 | A1 |
| 20030187338 | Say et al. | Oct 2003 | A1 |
| 20030191377 | Robinson et al. | Oct 2003 | A1 |
| 20030199744 | Buse et al. | Oct 2003 | A1 |
| 20030199790 | Boecker et al. | Oct 2003 | A1 |
| 20030208113 | Mault et al. | Nov 2003 | A1 |
| 20030212317 | Kovatchev et al. | Nov 2003 | A1 |
| 20030212379 | Bylund et al. | Nov 2003 | A1 |
| 20030216630 | Jersey-Willuhn et al. | Nov 2003 | A1 |
| 20030217966 | Tapsak et al. | Nov 2003 | A1 |
| 20030235817 | Bartkowiak et al. | Dec 2003 | A1 |
| 20040010186 | Kimball et al. | Jan 2004 | A1 |
| 20040010207 | Flaherty et al. | Jan 2004 | A1 |
| 20040011671 | Shults et al. | Jan 2004 | A1 |
| 20040018486 | Dunn et al. | Jan 2004 | A1 |
| 20040022438 | Hibbard | Feb 2004 | A1 |
| 20040024553 | Monfre et al. | Feb 2004 | A1 |
| 20040039298 | Abreu | Feb 2004 | A1 |
| 20040040840 | Mao et al. | Mar 2004 | A1 |
| 20040045879 | Shults et al. | Mar 2004 | A1 |
| 20040054263 | Moerman et al. | Mar 2004 | A1 |
| 20040064068 | DeNuzzio et al. | Apr 2004 | A1 |
| 20040077962 | Kroll | Apr 2004 | A1 |
| 20040078065 | Kroll | Apr 2004 | A1 |
| 20040093167 | Braig et al. | May 2004 | A1 |
| 20040099529 | Mao et al. | May 2004 | A1 |
| 20040106858 | Say et al. | Jun 2004 | A1 |
| 20040122353 | Shahmirian et al. | Jun 2004 | A1 |
| 20040127777 | Ruchti et al. | Jul 2004 | A1 |
| 20040133164 | Funderburk et al. | Jul 2004 | A1 |
| 20040135684 | Steinthal et al. | Jul 2004 | A1 |
| 20040138588 | Saikley et al. | Jul 2004 | A1 |
| 20040138716 | Kon et al. | Jul 2004 | A1 |
| 20040142403 | Hetzel et al. | Jul 2004 | A1 |
| 20040146909 | Duong et al. | Jul 2004 | A1 |
| 20040152622 | Keith et al. | Aug 2004 | A1 |
| 20040162678 | Hetzel et al. | Aug 2004 | A1 |
| 20040167801 | Say et al. | Aug 2004 | A1 |
| 20040171921 | Say et al. | Sep 2004 | A1 |
| 20040172307 | Gruber | Sep 2004 | A1 |
| 20040176672 | Silver et al. | Sep 2004 | A1 |
| 20040186362 | Brauker et al. | Sep 2004 | A1 |
| 20040186365 | Jin et al. | Sep 2004 | A1 |
| 20040193025 | Steil et al. | Sep 2004 | A1 |
| 20040193090 | Lebel et al. | Sep 2004 | A1 |
| 20040197846 | Hockersmith et al. | Oct 2004 | A1 |
| 20040199056 | Husemann et al. | Oct 2004 | A1 |
| 20040199059 | Brauker et al. | Oct 2004 | A1 |
| 20040204687 | Mogensen et al. | Oct 2004 | A1 |
| 20040208780 | Faries, Jr. et al. | Oct 2004 | A1 |
| 20040225338 | Lebel et al. | Nov 2004 | A1 |
| 20040236200 | Say et al. | Nov 2004 | A1 |
| 20040244151 | Sakata et al. | Dec 2004 | A1 |
| 20040249253 | Racchini et al. | Dec 2004 | A1 |
| 20040249420 | Olson et al. | Dec 2004 | A1 |
| 20040254433 | Bandis et al. | Dec 2004 | A1 |
| 20040254434 | Goodnow et al. | Dec 2004 | A1 |
| 20040260478 | Schwamm | Dec 2004 | A1 |
| 20040263354 | Mann et al. | Dec 2004 | A1 |
| 20040267300 | Mace | Dec 2004 | A1 |
| 20050003470 | Nelson et al. | Jan 2005 | A1 |
| 20050004439 | Shin et al. | Jan 2005 | A1 |
| 20050004494 | Perez et al. | Jan 2005 | A1 |
| 20050010087 | Banet et al. | Jan 2005 | A1 |
| 20050010269 | Lebel et al. | Jan 2005 | A1 |
| 20050016276 | Guan et al. | Jan 2005 | A1 |
| 20050017864 | Tsoukalis | Jan 2005 | A1 |
| 20050027177 | Shin et al. | Feb 2005 | A1 |
| 20050027180 | Goode et al. | Feb 2005 | A1 |
| 20050027181 | Goode et al. | Feb 2005 | A1 |
| 20050027462 | Goode et al. | Feb 2005 | A1 |
| 20050027463 | Goode et al. | Feb 2005 | A1 |
| 20050031689 | Shults et al. | Feb 2005 | A1 |
| 20050038332 | Saidara et al. | Feb 2005 | A1 |
| 20050043598 | Goode, Jr. et al. | Feb 2005 | A1 |
| 20050049179 | Davidson et al. | Mar 2005 | A1 |
| 20050049473 | Desai et al. | Mar 2005 | A1 |
| 20050059871 | Gough et al. | Mar 2005 | A1 |
| 20050069892 | Iyengar et al. | Mar 2005 | A1 |
| 20050070774 | Addison et al. | Mar 2005 | A1 |
| 20050090607 | Tapsak et al. | Apr 2005 | A1 |
| 20050096511 | Fox et al. | May 2005 | A1 |
| 20050096512 | Fox et al. | May 2005 | A1 |
| 20050112169 | Brauker et al. | May 2005 | A1 |
| 20050113653 | Fox et al. | May 2005 | A1 |
| 20050114068 | Chey et al. | May 2005 | A1 |
| 20050115832 | Simpson et al. | Jun 2005 | A1 |
| 20050121322 | Say et al. | Jun 2005 | A1 |
| 20050131346 | Douglas | Jun 2005 | A1 |
| 20050143635 | Kamath et al. | Jun 2005 | A1 |
| 20050143636 | Zhang et al. | Jun 2005 | A1 |
| 20050151976 | Toma | Jul 2005 | A1 |
| 20050154271 | Rasdal et al. | Jul 2005 | A1 |
| 20050176136 | Burd et al. | Aug 2005 | A1 |
| 20050177398 | Watanabe et al. | Aug 2005 | A1 |
| 20050182306 | Sloan | Aug 2005 | A1 |
| 20050187720 | Goode, Jr. et al. | Aug 2005 | A1 |
| 20050192494 | Ginsberg | Sep 2005 | A1 |
| 20050192557 | Brauker et al. | Sep 2005 | A1 |
| 20050195930 | Spital et al. | Sep 2005 | A1 |
| 20050196821 | Monfre et al. | Sep 2005 | A1 |
| 20050199494 | Say et al. | Sep 2005 | A1 |
| 20050203360 | Brauker et al. | Sep 2005 | A1 |
| 20050214892 | Kovatchev et al. | Sep 2005 | A1 |
| 20050215871 | Feldman et al. | Sep 2005 | A1 |
| 20050239154 | Feldman et al. | Oct 2005 | A1 |
| 20050239156 | Drucker et al. | Oct 2005 | A1 |
| 20050241957 | Mao et al. | Nov 2005 | A1 |
| 20050245795 | Goode, Jr. et al. | Nov 2005 | A1 |
| 20050245799 | Brauker et al. | Nov 2005 | A1 |
| 20050245839 | Stivoric et al. | Nov 2005 | A1 |
| 20050245904 | Estes et al. | Nov 2005 | A1 |
| 20050277164 | Drucker et al. | Dec 2005 | A1 |
| 20050277912 | John | Dec 2005 | A1 |
| 20050287620 | Heller et al. | Dec 2005 | A1 |
| 20050288725 | Hettrick et al. | Dec 2005 | A1 |
| 20060001538 | Kraft et al. | Jan 2006 | A1 |
| 20060004270 | Bedard et al. | Jan 2006 | A1 |
| 20060010098 | Goodnow et al. | Jan 2006 | A1 |
| 20060015020 | Neale et al. | Jan 2006 | A1 |
| 20060015024 | Brister et al. | Jan 2006 | A1 |
| 20060016700 | Brister et al. | Jan 2006 | A1 |
| 20060017923 | Ruchti et al. | Jan 2006 | A1 |
| 20060019327 | Brister et al. | Jan 2006 | A1 |
| 20060020186 | Brister et al. | Jan 2006 | A1 |
| 20060020187 | Brister et al. | Jan 2006 | A1 |
| 20060020188 | Kamath et al. | Jan 2006 | A1 |
| 20060020189 | Brister et al. | Jan 2006 | A1 |
| 20060020190 | Kamath et al. | Jan 2006 | A1 |
| 20060020191 | Brister et al. | Jan 2006 | A1 |
| 20060020192 | Brister et al. | Jan 2006 | A1 |
| 20060025662 | Buse et al. | Feb 2006 | A1 |
| 20060025663 | Talbot et al. | Feb 2006 | A1 |
| 20060029177 | Cranford, Jr. et al. | Feb 2006 | A1 |
| 20060031094 | Cohen et al. | Feb 2006 | A1 |
| 20060036139 | Brister et al. | Feb 2006 | A1 |
| 20060036140 | Brister et al. | Feb 2006 | A1 |
| 20060036141 | Kamath et al. | Feb 2006 | A1 |
| 20060036142 | Brister et al. | Feb 2006 | A1 |
| 20060036143 | Brister et al. | Feb 2006 | A1 |
| 20060036144 | Brister et al. | Feb 2006 | A1 |
| 20060036145 | Brister et al. | Feb 2006 | A1 |
| 20060058588 | Zdeblick | Mar 2006 | A1 |
| 20060091006 | Wang et al. | May 2006 | A1 |
| 20060094944 | Chuang | May 2006 | A1 |
| 20060094945 | Barman et al. | May 2006 | A1 |
| 20060142651 | Brister et al. | Jun 2006 | A1 |
| 20060155180 | Brister et al. | Jul 2006 | A1 |
| 20060166629 | Reggiardo | Jul 2006 | A1 |
| 20060167365 | Bharmi | Jul 2006 | A1 |
| 20060167517 | Gill et al. | Jul 2006 | A1 |
| 20060167518 | Gill et al. | Jul 2006 | A1 |
| 20060167519 | Gill et al. | Jul 2006 | A1 |
| 20060173260 | Gaoni et al. | Aug 2006 | A1 |
| 20060173406 | Hayes et al. | Aug 2006 | A1 |
| 20060173444 | Choy et al. | Aug 2006 | A1 |
| 20060183984 | Dobbles et al. | Aug 2006 | A1 |
| 20060183985 | Brister et al. | Aug 2006 | A1 |
| 20060189851 | Tvig et al. | Aug 2006 | A1 |
| 20060189863 | Peyser et al. | Aug 2006 | A1 |
| 20060193375 | Lee | Aug 2006 | A1 |
| 20060222566 | Brauker et al. | Oct 2006 | A1 |
| 20060224109 | Steil et al. | Oct 2006 | A1 |
| 20060226985 | Goodnow et al. | Oct 2006 | A1 |
| 20060229512 | Petisce et al. | Oct 2006 | A1 |
| 20060247508 | Fennell | Nov 2006 | A1 |
| 20060247685 | Bharmi | Nov 2006 | A1 |
| 20060247710 | Goetz et al. | Nov 2006 | A1 |
| 20060247985 | Liamos et al. | Nov 2006 | A1 |
| 20060258929 | Goode, Jr. et al. | Nov 2006 | A1 |
| 20060258959 | Sode | Nov 2006 | A1 |
| 20060264785 | Dring et al. | Nov 2006 | A1 |
| 20060272652 | Stocker et al. | Dec 2006 | A1 |
| 20060281985 | Ward et al. | Dec 2006 | A1 |
| 20060287691 | Drew | Dec 2006 | A1 |
| 20060293576 | Van Antwerp et al. | Dec 2006 | A1 |
| 20070016381 | Kamath et al. | Jan 2007 | A1 |
| 20070027381 | Stafford | Feb 2007 | A1 |
| 20070032706 | Kamath et al. | Feb 2007 | A1 |
| 20070033074 | Nitzan et al. | Feb 2007 | A1 |
| 20070038044 | Dobbles et al. | Feb 2007 | A1 |
| 20070055799 | Koehler et al. | Mar 2007 | A1 |
| 20070056858 | Chen et al. | Mar 2007 | A1 |
| 20070060803 | Liljeryd et al. | Mar 2007 | A1 |
| 20070060814 | Stafford | Mar 2007 | A1 |
| 20070066873 | Kamath et al. | Mar 2007 | A1 |
| 20070068807 | Feldman et al. | Mar 2007 | A1 |
| 20070071681 | Gadkar et al. | Mar 2007 | A1 |
| 20070073129 | Shah et al. | Mar 2007 | A1 |
| 20070078320 | Stafford | Apr 2007 | A1 |
| 20070078321 | Mazza et al. | Apr 2007 | A1 |
| 20070078322 | Stafford | Apr 2007 | A1 |
| 20070078323 | Reggiardo et al. | Apr 2007 | A1 |
| 20070095661 | Wang et al. | May 2007 | A1 |
| 20070106135 | Sloan et al. | May 2007 | A1 |
| 20070108048 | Wang et al. | May 2007 | A1 |
| 20070118030 | Bruce et al. | May 2007 | A1 |
| 20070118405 | Campbell et al. | May 2007 | A1 |
| 20070124002 | Estes et al. | May 2007 | A1 |
| 20070129621 | Kellogg et al. | Jun 2007 | A1 |
| 20070149875 | Ouyang et al. | Jun 2007 | A1 |
| 20070156033 | Causey, III et al. | Jul 2007 | A1 |
| 20070163880 | Woo et al. | Jul 2007 | A1 |
| 20070168224 | Letzt et al. | Jul 2007 | A1 |
| 20070173706 | Neinast et al. | Jul 2007 | A1 |
| 20070173709 | Petisce et al. | Jul 2007 | A1 |
| 20070173710 | Petisce et al. | Jul 2007 | A1 |
| 20070173761 | Kanderian et al. | Jul 2007 | A1 |
| 20070179349 | Hoyme et al. | Aug 2007 | A1 |
| 20070179352 | Randlov et al. | Aug 2007 | A1 |
| 20070179434 | Weinert et al. | Aug 2007 | A1 |
| 20070191701 | Feldman et al. | Aug 2007 | A1 |
| 20070199818 | Petyt et al. | Aug 2007 | A1 |
| 20070202562 | Curry et al. | Aug 2007 | A1 |
| 20070203407 | Hoss et al. | Aug 2007 | A1 |
| 20070203966 | Brauker et al. | Aug 2007 | A1 |
| 20070213657 | Jennewine et al. | Sep 2007 | A1 |
| 20070227911 | Wang et al. | Oct 2007 | A1 |
| 20070232877 | He | Oct 2007 | A1 |
| 20070232878 | Kovatchev et al. | Oct 2007 | A1 |
| 20070232880 | Siddiqui et al. | Oct 2007 | A1 |
| 20070233013 | Schoenberg et al. | Oct 2007 | A1 |
| 20070235331 | Simpson et al. | Oct 2007 | A1 |
| 20070244383 | Talbot et al. | Oct 2007 | A1 |
| 20070249922 | Peyser et al. | Oct 2007 | A1 |
| 20070253021 | Mehta et al. | Nov 2007 | A1 |
| 20070255321 | Gerber et al. | Nov 2007 | A1 |
| 20070255531 | Drew | Nov 2007 | A1 |
| 20070258395 | Jollota et al. | Nov 2007 | A1 |
| 20070270672 | Hayter | Nov 2007 | A1 |
| 20070285238 | Batra | Dec 2007 | A1 |
| 20070299617 | Willis | Dec 2007 | A1 |
| 20080004515 | Jennewine et al. | Jan 2008 | A1 |
| 20080004601 | Jennewine et al. | Jan 2008 | A1 |
| 20080009692 | Stafford | Jan 2008 | A1 |
| 20080012701 | Kass et al. | Jan 2008 | A1 |
| 20080017522 | Heller et al. | Jan 2008 | A1 |
| 20080018433 | Pitt-Pladdy | Jan 2008 | A1 |
| 20080021666 | Goode, Jr. et al. | Jan 2008 | A1 |
| 20080021972 | Huelskamp et al. | Jan 2008 | A1 |
| 20080029391 | Mao et al. | Feb 2008 | A1 |
| 20080030369 | Mann et al. | Feb 2008 | A1 |
| 20080033254 | Kamath et al. | Feb 2008 | A1 |
| 20080039702 | Hayter et al. | Feb 2008 | A1 |
| 20080045824 | Tapsak et al. | Feb 2008 | A1 |
| 20080058625 | McGarraugh et al. | Mar 2008 | A1 |
| 20080064937 | McGarraugh et al. | Mar 2008 | A1 |
| 20080064943 | Talbot et al. | Mar 2008 | A1 |
| 20080066305 | Wang et al. | Mar 2008 | A1 |
| 20080071156 | Brister et al. | Mar 2008 | A1 |
| 20080071157 | McGarraugh et al. | Mar 2008 | A1 |
| 20080071158 | McGarraugh et al. | Mar 2008 | A1 |
| 20080071328 | Haubrich et al. | Mar 2008 | A1 |
| 20080081977 | Hayter et al. | Apr 2008 | A1 |
| 20080083617 | Simpson et al. | Apr 2008 | A1 |
| 20080086042 | Brister et al. | Apr 2008 | A1 |
| 20080086044 | Brister et al. | Apr 2008 | A1 |
| 20080086273 | Shults et al. | Apr 2008 | A1 |
| 20080087544 | Zhou et al. | Apr 2008 | A1 |
| 20080097289 | Steil et al. | Apr 2008 | A1 |
| 20080102441 | Chen et al. | May 2008 | A1 |
| 20080108942 | Brister et al. | May 2008 | A1 |
| 20080119703 | Brister et al. | May 2008 | A1 |
| 20080119705 | Patel et al. | May 2008 | A1 |
| 20080119708 | Budiman | May 2008 | A1 |
| 20080139910 | Mastrototaro et al. | Jun 2008 | A1 |
| 20080148873 | Wang | Jun 2008 | A1 |
| 20080154513 | Kovatchev et al. | Jun 2008 | A1 |
| 20080161666 | Feldman et al. | Jul 2008 | A1 |
| 20080167543 | Say et al. | Jul 2008 | A1 |
| 20080167572 | Stivoric et al. | Jul 2008 | A1 |
| 20080172205 | Breton et al. | Jul 2008 | A1 |
| 20080177149 | Weinert et al. | Jul 2008 | A1 |
| 20080177165 | Blomquist et al. | Jul 2008 | A1 |
| 20080183060 | Steil et al. | Jul 2008 | A1 |
| 20080183061 | Goode et al. | Jul 2008 | A1 |
| 20080183399 | Goode et al. | Jul 2008 | A1 |
| 20080188731 | Brister et al. | Aug 2008 | A1 |
| 20080188796 | Steil et al. | Aug 2008 | A1 |
| 20080189051 | Goode et al. | Aug 2008 | A1 |
| 20080194934 | Ray et al. | Aug 2008 | A1 |
| 20080194935 | Brister et al. | Aug 2008 | A1 |
| 20080194936 | Goode et al. | Aug 2008 | A1 |
| 20080194937 | Goode et al. | Aug 2008 | A1 |
| 20080194938 | Brister et al. | Aug 2008 | A1 |
| 20080195232 | Carr-Brendel et al. | Aug 2008 | A1 |
| 20080195967 | Goode et al. | Aug 2008 | A1 |
| 20080197024 | Simpson et al. | Aug 2008 | A1 |
| 20080200788 | Brister et al. | Aug 2008 | A1 |
| 20080200789 | Brister et al. | Aug 2008 | A1 |
| 20080200791 | Simpson et al. | Aug 2008 | A1 |
| 20080201325 | Doniger et al. | Aug 2008 | A1 |
| 20080208025 | Shults et al. | Aug 2008 | A1 |
| 20080208113 | Damiano et al. | Aug 2008 | A1 |
| 20080214910 | Buck | Sep 2008 | A1 |
| 20080214915 | Brister et al. | Sep 2008 | A1 |
| 20080214918 | Brister et al. | Sep 2008 | A1 |
| 20080228051 | Shults et al. | Sep 2008 | A1 |
| 20080228054 | Shults et al. | Sep 2008 | A1 |
| 20080234943 | Ray et al. | Sep 2008 | A1 |
| 20080235469 | Drew | Sep 2008 | A1 |
| 20080242961 | Brister et al. | Oct 2008 | A1 |
| 20080242963 | Essenpreis et al. | Oct 2008 | A1 |
| 20080255434 | Hayter et al. | Oct 2008 | A1 |
| 20080255437 | Hayter | Oct 2008 | A1 |
| 20080255438 | Saidara et al. | Oct 2008 | A1 |
| 20080255808 | Hayter | Oct 2008 | A1 |
| 20080256048 | Hayter | Oct 2008 | A1 |
| 20080262469 | Brister et al. | Oct 2008 | A1 |
| 20080267823 | Wang et al. | Oct 2008 | A1 |
| 20080275313 | Brister et al. | Nov 2008 | A1 |
| 20080278332 | Fennel et al. | Nov 2008 | A1 |
| 20080287761 | Hayter | Nov 2008 | A1 |
| 20080287762 | Hayter | Nov 2008 | A1 |
| 20080287763 | Hayter | Nov 2008 | A1 |
| 20080287764 | Rasdal et al. | Nov 2008 | A1 |
| 20080287765 | Rasdal et al. | Nov 2008 | A1 |
| 20080287766 | Rasdal et al. | Nov 2008 | A1 |
| 20080288180 | Hayter | Nov 2008 | A1 |
| 20080288204 | Hayter et al. | Nov 2008 | A1 |
| 20080296155 | Shults et al. | Dec 2008 | A1 |
| 20080300572 | Rankers et al. | Dec 2008 | A1 |
| 20080306368 | Goode et al. | Dec 2008 | A1 |
| 20080306434 | Dobbles et al. | Dec 2008 | A1 |
| 20080306435 | Kamath et al. | Dec 2008 | A1 |
| 20080306444 | Brister et al. | Dec 2008 | A1 |
| 20080312518 | Jina et al. | Dec 2008 | A1 |
| 20080312841 | Hayter | Dec 2008 | A1 |
| 20080312842 | Hayter | Dec 2008 | A1 |
| 20080312844 | Hayter et al. | Dec 2008 | A1 |
| 20080312845 | Hayter et al. | Dec 2008 | A1 |
| 20080314395 | Kovatchev et al. | Dec 2008 | A1 |
| 20080319279 | Ramsay et al. | Dec 2008 | A1 |
| 20080319295 | Bernstein et al. | Dec 2008 | A1 |
| 20080319296 | Bernstein et al. | Dec 2008 | A1 |
| 20090005665 | Hayter et al. | Jan 2009 | A1 |
| 20090005666 | Shin et al. | Jan 2009 | A1 |
| 20090006034 | Hayter et al. | Jan 2009 | A1 |
| 20090006061 | Thukral et al. | Jan 2009 | A1 |
| 20090012376 | Agus | Jan 2009 | A1 |
| 20090012379 | Goode et al. | Jan 2009 | A1 |
| 20090018424 | Kamath et al. | Jan 2009 | A1 |
| 20090018425 | Ouyang et al. | Jan 2009 | A1 |
| 20090030293 | Cooper et al. | Jan 2009 | A1 |
| 20090030294 | Petisce et al. | Jan 2009 | A1 |
| 20090033482 | Hayter et al. | Feb 2009 | A1 |
| 20090036747 | Hayter et al. | Feb 2009 | A1 |
| 20090036758 | Brauker et al. | Feb 2009 | A1 |
| 20090036760 | Hayter | Feb 2009 | A1 |
| 20090036763 | Brauker et al. | Feb 2009 | A1 |
| 20090043181 | Brauker et al. | Feb 2009 | A1 |
| 20090043182 | Brauker et al. | Feb 2009 | A1 |
| 20090043525 | Brauker et al. | Feb 2009 | A1 |
| 20090043541 | Brauker et al. | Feb 2009 | A1 |
| 20090043542 | Brauker et al. | Feb 2009 | A1 |
| 20090045055 | Rhodes et al. | Feb 2009 | A1 |
| 20090048503 | Dalal et al. | Feb 2009 | A1 |
| 20090054745 | Jennewine et al. | Feb 2009 | A1 |
| 20090054748 | Feldman et al. | Feb 2009 | A1 |
| 20090054749 | He | Feb 2009 | A1 |
| 20090054753 | Robinson et al. | Feb 2009 | A1 |
| 20090055149 | Hayter et al. | Feb 2009 | A1 |
| 20090062633 | Brauker et al. | Mar 2009 | A1 |
| 20090062635 | Brauker et al. | Mar 2009 | A1 |
| 20090062767 | VanAntwerp et al. | Mar 2009 | A1 |
| 20090063402 | Hayter | Mar 2009 | A1 |
| 20090069649 | Budiman | Mar 2009 | A1 |
| 20090076356 | Simpson et al. | Mar 2009 | A1 |
| 20090076360 | Brister et al. | Mar 2009 | A1 |
| 20090076361 | Kamath et al. | Mar 2009 | A1 |
| 20090082693 | Stafford | Mar 2009 | A1 |
| 20090085768 | Patel et al. | Apr 2009 | A1 |
| 20090099436 | Brister et al. | Apr 2009 | A1 |
| 20090102678 | Mazza et al. | Apr 2009 | A1 |
| 20090105554 | Stahmann et al. | Apr 2009 | A1 |
| 20090105570 | Sloan et al. | Apr 2009 | A1 |
| 20090105636 | Hayter et al. | Apr 2009 | A1 |
| 20090112478 | Mueller, Jr. et al. | Apr 2009 | A1 |
| 20090112626 | Talbot et al. | Apr 2009 | A1 |
| 20090118589 | Ueshima et al. | May 2009 | A1 |
| 20090124877 | Goode, Jr. et al. | May 2009 | A1 |
| 20090124878 | Goode et al. | May 2009 | A1 |
| 20090124879 | Brister et al. | May 2009 | A1 |
| 20090124964 | Leach et al. | May 2009 | A1 |
| 20090131768 | Simpson et al. | May 2009 | A1 |
| 20090131769 | Leach et al. | May 2009 | A1 |
| 20090131776 | Simpson et al. | May 2009 | A1 |
| 20090131777 | Simpson et al. | May 2009 | A1 |
| 20090137886 | Shariati et al. | May 2009 | A1 |
| 20090137887 | Shariati et al. | May 2009 | A1 |
| 20090143659 | Li et al. | Jun 2009 | A1 |
| 20090143660 | Brister et al. | Jun 2009 | A1 |
| 20090143725 | Peyser et al. | Jun 2009 | A1 |
| 20090149728 | Van Antwerp et al. | Jun 2009 | A1 |
| 20090150186 | Cohen et al. | Jun 2009 | A1 |
| 20090156919 | Brister et al. | Jun 2009 | A1 |
| 20090156924 | Shariati et al. | Jun 2009 | A1 |
| 20090163789 | Say et al. | Jun 2009 | A1 |
| 20090163790 | Brister et al. | Jun 2009 | A1 |
| 20090163791 | Brister et al. | Jun 2009 | A1 |
| 20090163855 | Shin et al. | Jun 2009 | A1 |
| 20090164190 | Hayter | Jun 2009 | A1 |
| 20090164239 | Hayter et al. | Jun 2009 | A1 |
| 20090164251 | Hayter | Jun 2009 | A1 |
| 20090178459 | Li et al. | Jul 2009 | A1 |
| 20090182217 | Li et al. | Jul 2009 | A1 |
| 20090182517 | Gandhi et al. | Jul 2009 | A1 |
| 20090189738 | Hermle | Jul 2009 | A1 |
| 20090192366 | Mensinger et al. | Jul 2009 | A1 |
| 20090192380 | Shariati et al. | Jul 2009 | A1 |
| 20090192722 | Shariati et al. | Jul 2009 | A1 |
| 20090192724 | Brauker et al. | Jul 2009 | A1 |
| 20090192745 | Kamath et al. | Jul 2009 | A1 |
| 20090192751 | Kamath et al. | Jul 2009 | A1 |
| 20090198118 | Hayter et al. | Aug 2009 | A1 |
| 20090203981 | Brauker et al. | Aug 2009 | A1 |
| 20090204341 | Brauker et al. | Aug 2009 | A1 |
| 20090216103 | Brister et al. | Aug 2009 | A1 |
| 20090234200 | Husheer | Sep 2009 | A1 |
| 20090240120 | Mensinger et al. | Sep 2009 | A1 |
| 20090240128 | Mensinger et al. | Sep 2009 | A1 |
| 20090240193 | Mensinger et al. | Sep 2009 | A1 |
| 20090242399 | Kamath et al. | Oct 2009 | A1 |
| 20090242425 | Kamath et al. | Oct 2009 | A1 |
| 20090247855 | Boock et al. | Oct 2009 | A1 |
| 20090247856 | Boock et al. | Oct 2009 | A1 |
| 20090247857 | Harper et al. | Oct 2009 | A1 |
| 20090257911 | Thomas et al. | Oct 2009 | A1 |
| 20090267765 | Greene et al. | Oct 2009 | A1 |
| 20090281407 | Budiman | Nov 2009 | A1 |
| 20090287073 | Boock et al. | Nov 2009 | A1 |
| 20090287074 | Shults et al. | Nov 2009 | A1 |
| 20090289796 | Blumberg | Nov 2009 | A1 |
| 20090294277 | Thomas et al. | Dec 2009 | A1 |
| 20090299155 | Yang et al. | Dec 2009 | A1 |
| 20090299156 | Simpson et al. | Dec 2009 | A1 |
| 20090299162 | Brauker et al. | Dec 2009 | A1 |
| 20090299276 | Brauker et al. | Dec 2009 | A1 |
| 20100010324 | Brauker et al. | Jan 2010 | A1 |
| 20100010331 | Brauker et al. | Jan 2010 | A1 |
| 20100010332 | Brauker et al. | Jan 2010 | A1 |
| 20100057040 | Hayter | Mar 2010 | A1 |
| 20100057041 | Hayter | Mar 2010 | A1 |
| 20100057042 | Hayter | Mar 2010 | A1 |
| 20100057044 | Hayter | Mar 2010 | A1 |
| 20100057057 | Hayter et al. | Mar 2010 | A1 |
| 20100063372 | Potts et al. | Mar 2010 | A1 |
| 20100064764 | Hayter et al. | Mar 2010 | A1 |
| 20100081906 | Hayter et al. | Apr 2010 | A1 |
| 20100081909 | Budiman et al. | Apr 2010 | A1 |
| 20100081953 | Syeda-Mahmood et al. | Apr 2010 | A1 |
| 20100121167 | McGarraugh et al. | May 2010 | A1 |
| 20100141656 | Krieftewirth | Jun 2010 | A1 |
| 20100145377 | Lai et al. | Jun 2010 | A1 |
| 20100152561 | Goodnow et al. | Jun 2010 | A1 |
| 20100160759 | Celentano et al. | Jun 2010 | A1 |
| 20100160761 | Say et al. | Jun 2010 | A1 |
| 20100168538 | Keenan et al. | Jul 2010 | A1 |
| 20100168546 | Kamath et al. | Jul 2010 | A1 |
| 20100174266 | Estes | Jul 2010 | A1 |
| 20100190435 | Cook et al. | Jul 2010 | A1 |
| 20100191085 | Budiman | Jul 2010 | A1 |
| 20100191472 | Doniger et al. | Jul 2010 | A1 |
| 20100198034 | Thomas et al. | Aug 2010 | A1 |
| 20100198142 | Sloan et al. | Aug 2010 | A1 |
| 20100204557 | Kiaie et al. | Aug 2010 | A1 |
| 20100213057 | Feldman et al. | Aug 2010 | A1 |
| 20100230285 | Hoss | Sep 2010 | A1 |
| 20100234710 | Budiman et al. | Sep 2010 | A1 |
| 20100261987 | Kamath et al. | Oct 2010 | A1 |
| 20100265073 | Harper et al. | Oct 2010 | A1 |
| 20100274515 | Hoss et al. | Oct 2010 | A1 |
| 20100277342 | Sicurello et al. | Nov 2010 | A1 |
| 20100280441 | Willinska et al. | Nov 2010 | A1 |
| 20100280782 | Harper et al. | Nov 2010 | A1 |
| 20100313105 | Nekoomaram et al. | Dec 2010 | A1 |
| 20100317952 | Budiman et al. | Dec 2010 | A1 |
| 20100324392 | Yee et al. | Dec 2010 | A1 |
| 20100326842 | Mazza et al. | Dec 2010 | A1 |
| 20110004276 | Blair et al. | Jan 2011 | A1 |
| 20110021889 | Hoss et al. | Jan 2011 | A1 |
| 20110024043 | Boock et al. | Feb 2011 | A1 |
| 20110024307 | Simpson et al. | Feb 2011 | A1 |
| 20110027127 | Simpson et al. | Feb 2011 | A1 |
| 20110027453 | Boock et al. | Feb 2011 | A1 |
| 20110027458 | Boock et al. | Feb 2011 | A1 |
| 20110028815 | Simpson et al. | Feb 2011 | A1 |
| 20110028816 | Simpson et al. | Feb 2011 | A1 |
| 20110029247 | Kalathil | Feb 2011 | A1 |
| 20110036714 | Zhou et al. | Feb 2011 | A1 |
| 20110040163 | Telson et al. | Feb 2011 | A1 |
| 20110060530 | Fennell | Mar 2011 | A1 |
| 20110077490 | Simpson et al. | Mar 2011 | A1 |
| 20110077494 | Doniger et al. | Mar 2011 | A1 |
| 20110081726 | Berman et al. | Apr 2011 | A1 |
| 20110082484 | Saravia et al. | Apr 2011 | A1 |
| 20110105873 | Feldman et al. | May 2011 | A1 |
| 20110106126 | Love et al. | May 2011 | A1 |
| 20110112696 | Yodfat et al. | May 2011 | A1 |
| 20110148905 | Simmons et al. | Jun 2011 | A1 |
| 20110152637 | Kateraas et al. | Jun 2011 | A1 |
| 20110184268 | Taub | Jul 2011 | A1 |
| 20110190603 | Stafford | Aug 2011 | A1 |
| 20110191044 | Stafford | Aug 2011 | A1 |
| 20110193704 | Harper et al. | Aug 2011 | A1 |
| 20110208027 | Wagner et al. | Aug 2011 | A1 |
| 20110208155 | Palerm et al. | Aug 2011 | A1 |
| 20110213225 | Bernstein et al. | Sep 2011 | A1 |
| 20110224523 | Budiman | Sep 2011 | A1 |
| 20110257495 | Hoss et al. | Oct 2011 | A1 |
| 20110257895 | Brauker et al. | Oct 2011 | A1 |
| 20110263958 | Brauker et al. | Oct 2011 | A1 |
| 20110288574 | Curry et al. | Nov 2011 | A1 |
| 20110319729 | Donnay et al. | Dec 2011 | A1 |
| 20110320130 | Valdes et al. | Dec 2011 | A1 |
| 20110320167 | Budiman | Dec 2011 | A1 |
| 20120010642 | Lee et al. | Jan 2012 | A1 |
| 20120078071 | Bohm et al. | Mar 2012 | A1 |
| 20120108931 | Taub | May 2012 | A1 |
| 20120108934 | Valdes et al. | May 2012 | A1 |
| 20120165626 | Irina et al. | Jun 2012 | A1 |
| 20120165640 | Galley et al. | Jun 2012 | A1 |
| 20120173200 | Breton et al. | Jul 2012 | A1 |
| 20120209099 | Ljuhs et al. | Aug 2012 | A1 |
| 20120215462 | Goode et al. | Aug 2012 | A1 |
| 20120245447 | Karan et al. | Sep 2012 | A1 |
| 20120277565 | Budiman | Nov 2012 | A1 |
| 20120283542 | McGarraugh | Nov 2012 | A1 |
| 20120318670 | Karinka et al. | Dec 2012 | A1 |
| 20130035575 | Mayou et al. | Feb 2013 | A1 |
| 20130137953 | Harper et al. | May 2013 | A1 |
| 20130184547 | Taub et al. | Jul 2013 | A1 |
| 20130231541 | Hayter et al. | Sep 2013 | A1 |
| 20130324823 | Koski et al. | Dec 2013 | A1 |
| 20140005499 | Catt et al. | Jan 2014 | A1 |
| 20140046160 | Terashima et al. | Feb 2014 | A1 |
| 20140088392 | Bernstein et al. | Mar 2014 | A1 |
| 20140121480 | Budiman et al. | May 2014 | A1 |
| 20140121488 | Budiman | May 2014 | A1 |
| 20140221966 | Buckingham et al. | Aug 2014 | A1 |
| 20150005601 | Hoss et al. | Jan 2015 | A1 |
| 20150216456 | Budiman | Aug 2015 | A1 |
| 20150241407 | Ou et al. | Aug 2015 | A1 |
| 20150366510 | Budiman | Dec 2015 | A1 |
| 20160022221 | Ou et al. | Jan 2016 | A1 |
| 20160302701 | Bhavaraju et al. | Oct 2016 | A1 |
| 20170112531 | Schoonmaker et al. | Apr 2017 | A1 |
| 20190274598 | Scott et al. | Sep 2019 | A1 |
| 20220142518 | Budiman et al. | May 2022 | A1 |
| Number | Date | Country |
|---|---|---|
| 0098592 | Jan 1984 | EP |
| 0127958 | Dec 1984 | EP |
| 0320109 | Jun 1989 | EP |
| 0353328 | Feb 1990 | EP |
| 0390390 | Oct 1990 | EP |
| 0396788 | Nov 1990 | EP |
| 0472411 | Feb 1992 | EP |
| 0286118 | Jan 1995 | EP |
| 0867146 | Sep 1998 | EP |
| 1048264 | Nov 2000 | EP |
| 1391728 | Feb 2004 | EP |
| 1419731 | May 2004 | EP |
| 0939602 | Sep 2004 | EP |
| 1850909 | Apr 2010 | EP |
| 1677668 | Jul 2010 | EP |
| 1 413 879 | Jan 2012 | EP |
| 3575796 | Dec 2019 | EP |
| WO-1996025089 | Aug 1996 | WO |
| WO-1996035370 | Nov 1996 | WO |
| WO-1997015227 | May 1997 | WO |
| WO-1998035053 | Aug 1998 | WO |
| WO-1999056613 | Nov 1999 | WO |
| WO-0049941 | Aug 2000 | WO |
| WO-2000049940 | Aug 2000 | WO |
| WO-2000059370 | Oct 2000 | WO |
| WO-2000074753 | Dec 2000 | WO |
| WO-2001052935 | Jul 2001 | WO |
| WO-2001054753 | Aug 2001 | WO |
| WO-2002016905 | Feb 2002 | WO |
| WO 02058537 | Aug 2002 | WO |
| WO-03012422 | Feb 2003 | WO |
| WO-03032411 | Apr 2003 | WO |
| WO-2003076893 | Sep 2003 | WO |
| WO-2003082091 | Oct 2003 | WO |
| WO-03094714 | Nov 2003 | WO |
| WO-2004060455 | Jul 2004 | WO |
| WO-2005010756 | Feb 2005 | WO |
| WO-2005011489 | Feb 2005 | WO |
| WO-2005065542 | Jul 2005 | WO |
| WO-2005070287 | Aug 2005 | WO |
| WO-2006024671 | Mar 2006 | WO |
| WO 2006026741 | Mar 2006 | WO |
| WO-2006081336 | Aug 2006 | WO |
| WO-2007097754 | Aug 2007 | WO |
| WO-2008021913 | Feb 2008 | WO |
| WO-2008086541 | Jul 2008 | WO |
| WO-2010022387 | Feb 2010 | WO |
| WO-2010099507 | Sep 2010 | WO |
| WO-2011011643 | Jan 2011 | WO |
| WO-2012142502 | Oct 2012 | WO |
| Entry |
|---|
| U.S. Appl. No. 61/227,967, filed Jul. 23, 2009, Hoss, et al. |
| Bard, A. J., et al., Electrochemical Methods, Fundamentals and Applications, John Wiley & Sons, pp. 174-175. |
| Chen, T., et al., “In Situ Assembled Mass-Transport Controlling Micromembranes and Their Application in Implanted Amperometric Glucose Sensors”, Analytical Chemistry, vol. 72, No. 16, 2000, pp. 3757-3763. |
| Chen, T., et al., In vivo Glucose Monitoring with Miniature “Wired” Glucose Oxidase Electrodes, Analytical Sciences, vol. 17, 2001, pp. i297-i300. |
| Chen, X., et al., “Glucose microbiosensor based on alumina sol gel matrix. electropolymerized composite membrane”, Biosensors and Bioelectronics, 2002, 9 pages. |
| Chung, T. D., “In vitro Evaluation of the Continuous Monitoring Glucose Sensors with Perfluorinated Tetrafluoroethylene Coatings”, Bull. Korean Chem. Soc., vol. 24, No. 4, 2003, pp. 514-516. |
| Cunningham, D. D., et al., “In Vivo Glucose Sensing”, Chemical Analysis: A Series of Monographs on Analytical Chemistry and Its Applications, vol. 174, John Wiley & Sons, Inc., 2010, 466 pages. |
| Freestyle Navigator, Continuous Glucose Monitoring System, User's Guide, 2008, Abbott, 195 pages. |
| Guardian® REAL-Time, Continuous Glucose Monitoring System, User Guide, Medtronic MiniMed, Inc., 2006, 181 pages. |
| Guardian® RT, Continuous Glucose Monitoring System, REF MMT-7900, User Guide, Medtronic MiniMed, 2005, 128 pages. |
| Heller, A., “Implanted Electrochemical Glucose Sensors for the Management of Diabetes”, Annual Review of Biomedical Engineering, vol. 1, 1999, pp. 153-175. |
| Heller, A., et al., “Electrochemical Glucose Sensors and Their Applications in Diabetes Management”, Chemical Reviews, 2008, pp. 2482-2505. |
| Jimenez, C., et al., “Glucose sensor based on an amperometric microelectrode with a photopolymerizable enzyme membrane”, Sensors and Actuators B 26-27, 1995, pp. 421-424. |
| Klonoff, D. C., et al., “Diabetes Technology & Therapeutics”, vol. 5, No. 4, 2003, 14 pages. |
| Moatti-Sirat, D., et al., Evaluating in vitro and in vivo the interference of ascorbate and acetaminophen on glucose detection by a needle-type glucose sensor, Biosensors & Bioelectronics, 7, 1992, pp. 345-349. |
| Nishida, K., et al., “Development of a ferrocene-mediated needle-type glucose sensor covered with newly designed biocompatible membrane, 2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate”, Medical Progress through Technology, vol. 21, 1995, pp. 91-103. |
| Rhodes, R. K., et al., “Prediction of Pocket-Portable and Implantable Glucose Enzyme Electrode Performance from Combined Species Permeability and Digital Simulation Analysis”, Analytical Chemistry. vol. 66, No. 9, 1994. pp. 1520-1529. |
| Summary of Safety and Effectiveness Data, FreeStyle Navigator® Continuous Glucose Monitoring System, Abbott Diabetes Care, 2008, 27 pages. |
| Tierney, M. J., et al., “Effect of Acetaminophen on the Accuracy of Glucose Measurements Obtained with the GlucoWatch Biographer”, Diabetes Technology & Therapeutics, vol. 2, No. 2, 2000, pp. 199-208. |
| Yang, S., et al., “Glucose Biosensors Based on Oxygen Electrode with Sandwich-Type Membranes”, Annals of Biomedical Engineering, vol. 23, 1995, pp. 833-839. |
| Yang, S., et al., “Glucose Biosensors with Enzyme Entrapped in Polymer Coating”, Original Research, Biomedical Instrumentation & Technology, 1995, pp. 125-133. |
| U.S. Appl. No. 16/256,855, filed Nov. 22, 2022 Response to Final Office Action with Request for Continued Examination and Terminal Disclaimer. |
| U.S. Appl. No. 16/256,855, filed Oct. 27, 2022 Final Office Action. |
| U.S. Appl. No. 16/256,855, filed Oct. 12, 2022 Response to Non-Final Office Action. |
| Abel, et al., “Biosensors for in vivo glucose measurement: can we cross the experimental stage”, Biosensors and Bioelectronics, 17:1059-1070 (2002). |
| Alcock, et al., “Continuous Analyte Monitoring to Aid Clinical Practice”, IEEE Engineering in Medicine and Biology, pp. 319-325 (1994). |
| Bequette, “Continuous Glucose Monitoring: Real Time Algorithms for Calibration, Filtering, and Alarms”, Journal of Diabetes Science and Technology, 4(2):404-418 (2010). |
| Cengiz, et al., “A Tale of Two Compartments: Interstitial Versus Blood Glucose Monitoring”, Diabetes Technology & Therapeutics, 11(1):S-11-S16 (2009). |
| Chen, et al., “Defining the Period of Recovery of the Glucose Concentration after Its Local Perturbation by the Implantation of a Miniature Sensor”, Clin Chem Lab Med, 40(8):786-789 (2002). |
| De Block, et al., “Minimally-Invasive and Non-Invasive Continuous Glucose Monitoring Systems: Indications, Advantages, Limitations and Clinical Aspects”, Current Diabetes Reviews, 4:159-168 (2008). |
| Facchinetti, et al., “Enhanced Accuracy of Continuous Glucose Monitoring by Online Extended Kalman Filtering”, Diabetes Technology & Therapeutics, 12(5):353-363 (2010). |
| Gerritsen, et al., “Subcutaneously implantable glucose sensors in patients with diabetes mellitus; still many problems”, Dutch Journal of Medicine, 146(28):1313-1316 (2002) (with English Machine Translation). |
| Heinemann, “Continuous Glucose Monitoring by Means of the Microdialysis Technique: Underlying Fundamental Aspects”, Diabetes Technology & Therapeutics, 5(4):545-561 (2003). |
| Knobbe, et al., “The Extended Kalman Filter for Continuous Glucose Monitoring”, Diabetes Technology & Therapeutics, 7(1):15-27 (2005). |
| Koudelka, et al., “In-vivo Behaviour of Hypodermically Implanted Microfabricated Glucose Sensors”, Biosensors & Bioelectronics, 6:31-36 (1991). |
| Koudelka-Hep, “Electrochemical Sensors for in vivo Glucose Sensing”, Biosensors in the Body: Continuous in vivo Monitoring, pp. 57-77 (1997). |
| Kvist, et al., “Recent Advances in Continuous Glucose Monitoring: Biocompatibility of Glucose Sensors for Implantation in Subcutis”, Journal of Diabetes Science and Technology, 1(5):746-752 (2007). |
| Ming Li, et al., “Implantable Electrochemical Sensors for Biomedical and Clinical Applications: Progress, Problems, and Future Possibilities”, Current Medicinal Chemistry, 14:937-951 (2007). |
| Onuki, et al., “A Review of the Biocompatibility of Implantable Devices: Current Challenges to Overcome Foreign Body Response”, Journal of Diabetes Science and Technology, 2(6):1003-1015 (2008). |
| Palerm, et al., “Hypoglycemia Prediction and Detection Using Optimal Estimation”, Diabetes Technology & Therapeutics, 7(1):3-14 (2005). |
| Poitout, et al., “Calibration in dogs of a subcutaneous miniaturized glucose sensor using a glucose meter for blood glucose determination”, Biosensors & Bioelectronics, 7:587-592 (1992). |
| Rebrin, et al., “Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring”, American Journal of Physiology-Endocrinology and Metabolism, 277(3):E561-E571 (1999). |
| Renard, “Implantable glucose sensors for diabetes monitoring”, Min Invas Ther & Allied Technol, 13(2):78-86 (2004). |
| Robert, “Continuous Monitoring of Blood Glucose”, Horm Res 57(suppl 1):81-84 (2002). |
| Schlosser, et al., “Biocompatibility of Active Implantable Devices”, Biosensors in the Body: Continuous in vivo Monitoring, pp. 139-170 (1997). |
| Schmidt, et al., “Calibration of a wearable glucose sensor”, The International Journal of Artificial Organs, 15(1):55-61 (1992). |
| Voskerician, et al., “Sensor Biocompatibility and Biofouling in Real-Time Monitoring”, Wiley Encyclopedia of Biomedical Engineering, (John Wiley & Sons, Inc.), pp. 1-19 (2006). |
| Ward, “A Review of the Foreign-body Response to Subcutaneously-implanted Devices: The Role of Macrophages and Cytokines in Biofouling and Fibrosis”, Journal of Diabetes Science and Technology, 2(5):768-777 (2008). |
| Ward, et al., “A new amperometric glucose microsensor: in vitro and short-term in vivo evaluation”, Biosensors & Bioelectronics, 17:181-189 (2002). |
| U.S. Appl. No. 16/256,855 (US 2019-0150802 A1), filed Jan. 24, 2019 (May 23, 2019). |
| U.S. Appl. No. 15/789,949 (U.S. Pat. No. 10,188,334), filed Oct. 20, 2017 (Jan. 29, 2019). |
| U.S. Appl. No. 15/616,916 (U.S. Pat. No. 9,801,577), filed Jun. 7, 2017 (Oct. 31, 2017). |
| U.S. Appl. No. 14/066,650 (U.S. Pat. No. 9,675,290), filed Oct. 29, 2013 (Jun. 13, 2017). |
| U.S. Appl. No. 16/256,855, Jul. 12, 2022 Non-Final Office Action. |
| U.S. Appl. No. 16/256,855, Jun. 23, 2022 TrackOne Request Granted. |
| U.S. Appl. No. 16/256,855, Jun. 1, 2022 Response to Final Office Action with Request for Continued Examination (RCE) & TrackOne Request. |
| U.S. Appl. No. 16/256,855, Apr. 1, 2022 Final Office Action. |
| U.S. Appl. No. 16/256,855, Mar. 7, 2022 Response to Non-Final Office Action. |
| U.S. Appl. No. 16/256,855, Jan. 7, 2022 Non-Final Office Action. |
| U.S. Appl. No. 16/256,855, Nov. 22, 2021 Response to Non-Final Office Action. |
| U.S. Appl. No. 16/256,855, Aug. 25, 2021 Non-Final Office Action. |
| Armour, J. C., et al., “Application of Chronic Intravascular Blood Glucose Sensor in Dogs”, Diabetes, vol. 39, 1990, pp. 1519-1526. |
| Arnold, M. A., et al., “Selectivity Assessment of Noninvasive Glucose Measurements Based on Analysis of Multivariate Calibration Vectors”, Journal of Diabetes Science and Technology, vol. 1, No. 4, 2007, pp. 454-462. |
| Bennion, N., et al., “Alternate Site Glucose Testing: A Crossover Design”, Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33. |
| Blank, T. B., et al., “Clinical Results From a Non-Invasive Blood Glucose Monitor”, Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10. |
| Boyne, M. S., et al., “Timing of Changes in Interstitial and Venous Blood Glucose Measured With a Continuous Subcutaneous Glucose Sensor”, Diabetes, vol. 52, Nov. 2003, pp. 2790-2794. |
| Bremer, T. M., et al., “Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies”, Diabetes Technology & Therapeutics vol. 3 No. 3, 2001, pp. 409-418. |
| Brooks, S. L., et al., “Development of an On-Line Glucose Sensor for Fermentation Monitoring”, Biosensors, vol. 3, 1987/88, pp. 45-56. |
| Cass, A. E., et al., “Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose”, Analytical Chemistry, vol. 56, No. 4, 1984, 667-671. |
| Cheyne, E. H., et al., Performance of a Continuous Glucose Monitoring System During Controlled Hypoglycaemia in Healthy Volunteers, Diabetes Technology & Therapeutics, vol. 4, No. 5, 2002, pp. 607-613. |
| Choleau, C., et al., “Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2. Superiority of the One-Point Calibration Method”, Biosensors and Bioelectronics, vol. 17, No. 8, 2002, pp. 647-654. |
| Csoregi, E., et al., “Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on ‘Wired’ Glucose Oxidase”, Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244. |
| Diabetes Control and Complications Trial Research Group, “The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus,” New England J. Med. vol. 329, 1993, pp. 977-986. |
| Eren-Oruklu, M., et al., “Estimation of Future Glucose Concentrations with Subject-Specific Recursive Linear Models”, Diabetes Technology & Therapeutics vol. 11(4), 2009, pp. 243-253. |
| Feldman, B., et al., “A Continuous Glucose Sensor Based on Wired Enzyme™ Technology Results from a 3-Day Trial in Patients with Type 1 Diabetes”, Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779. |
| Feldman, B., et al., “Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change”, Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004. |
| Georgescu, B., et al., “Real-Time Multimodel Tracking of Myocardium in Echocardiography Using Robust Information Fusion”, Medical Image Computing and Computer-Assisted Intervention, 2004, pp. 777-785. |
| Goldman, J. M., et al., “Masimo Signal Extraction Pulse Oximetry”, Journal of Clinical Monitoring and Computing, vol. 16, No. 7, 2000, pp. 475-483. |
| Guerci, B., et al., “Clinical Performance of CGMS in Type 1 Diabetic Patients Treated by Continuous Subcutaneous Insulin Infusion Using Insulin Analogs”, Diabetes Care, vol. 26, 2003, pp. 582-589. |
| Hovorka, R., et al., “Nonlinear Model Predictive Control of Glucose Concentration in Subjects with Type 1 Diabetes”, Physiological Measurement, vol. 55, Jul. 2004, pp. 905-920. |
| Isermann, R., “Supervision, Fault-Detection and Fault-Diagnosis Methods—an Introduction”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 639-652. |
| Isermann, R., et al., “Trends in the Application of Model-Based Fault Detection and Diagnosis of Technical Processes”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 709-719. |
| Johnson, P. C., “Peripheral Circulation”, John Wiley & Sons, 1978, pp. 198. |
| Jungheim, K., et al., “How Rapid Does Glucose Concentration Change in Daily Life of Patients with Type 1 Diabetes?”, 2002, pp. 250. |
| Jungheim, K., et al., “Risky Delay of Hypoglycemia Detection by Glucose Monitoring at the Arm”, Diabetes Care, vol. 24, No. 7, 2001, pp. 1303-1304. |
| Kaplan, S. M., “Wiley Electrical and Electronics Engineering Dictionary”, IEEE Press, 2004, pp. 141, 142, 548, 549. |
| Kovatchev, B. P., et al., “Evaluating the Accuracy of Continuous Glucose-Monitoring Sensors”, Diabetes Care, vol. 27, No. 8, 2004, pp. 1922-1928. |
| Kovatchev, B. P., et al., “Graphical and Numerical Evaluation of Continuous Glucose Sensing Time Lag”, Diabetes Technology & Therapeutics, vol. 11, No. 3, Feb. 2009, pp. 139-143. |
| Kuure-Kinsey, M., et al., “A Dual-Rate Kalman Filter for Continuous Glucose Monitoring”, Proceedings of the 28th IEEE, EMBS Annual International Conference, New York City, 2006, pp. 63-66. |
| Lodwig, V., et al., “Continuous Glucose Monitoring with Glucose Sensors: Calibration and Assessment Criteria”, Diabetes Technology & Therapeutics vol. 5 No. 4 2003, pp. 573-587. |
| Lortz, J., et al., “What is Bluetooth? We Explain the Newest Short-Range Connectivity Technology”, Smart Computing Learning Series, Wireless Computing, vol. 8, Issue 5, 2002, pp. 72-74. |
| Maher, “A Method for Extrapolation of Missing Digital Audio Data”, Preprints of Papers Presented at the AES Convention, 1993, pp. 1-19. |
| Maher, “Audio Enhancement using Nonlinear Time-Frequency Filtering”, AES 26th International Conference, 2005, pp. 1-9. |
| Malin, S. F., et al., “Noninvasive Prediction of Glucose by Near-Infrared Diffuse Reflectance Spectoscopy”, Clinical Chemistry, vol. 45, No. 9, 1999, pp. 1651-1658. |
| McGarraugh, G., et al., “Glucose Measurements Using Blood Extracted from the Forearm and the Finger”, TheraSense, Inc., 2001, 16 Pages. |
| McGarraugh, G., et al., “Physiological Influences on Off-Finger Glucose Testing”, Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 367-376. |
| McKean, B. D., et al., “A Telemetry-Instrumentation System for Chronically Implanted Glucose and Oxygen Sensors”, IEEE Transactions on Biomedical Engineering, vol. 35, No. 7, 1988, pp. 526-532. |
| Morbiducci, U, et al., “Improved Usability of the Minimal Model of Insulin Sensitivity Based on an Automated Approach and Genetic Algorithms for Parameter Estimation”, Clinical Science, vol. 112, 2007, pp. 257-263. |
| Mougiakakou, et al., “A Real Time Simulation Model of Glucose-Insulin Metabolism for Type 1 Diabetes Patients”, Proceedings of the 2005 IEEE, 2005, pp. 298-301. |
| Panteleon, A. E., et al., “The Role of the Independent Variable to Glucose Sensor Calibration”, Diabetes Technology & Therapeutics, vol. 5. No. 3, 2003, pp. 401-410. |
| Parker, R., et al., “Robust H..° Glucose Control in Diabetes Using a Physiological Model”, AIChE Journal, vol. 46, No. 12, 2000, pp. 2537-2549. |
| Pickup, J., et al., “Implantable Glucose Sensors: Choosing the Appropriate Sensing Strategy”, Biosensors, vol. 3, 1987/88, pp. 335-346. |
| Pickup, J., et al., “In Vivo Molecular Sensing in Diabetes Mellitus: An Implantable Glucose Sensor with Direct Electron Transfer”, Diabetologia, vol. 32, 1989, pp. 213-217. |
| Pishko, M. V., et al., “Amperometric Glucose Microelectrodes Prepared Through Immobilization of Glucose Oxidase in Redox Hydrogels”, Analytical Chemistry, vol. 63, No. 20, 1991, pp. 2268-2272. |
| Quinn, C. P., et al., “Kinetics of Glucose Delivery to Subcutaneous Tissue in Rats Measured with 0.3-mm Amperometric Microsensors”, The American Physiological Society, 1995, E155-E161. |
| Rodriguez, N., et al., “Flexible Communication and Control Protocol for Injectable Neuromuscular Interfaces”, IEEE Transactions on Biomedical Circuits and Systems, vol. 1, No. 1, 2007. pp. 19-27. |
| Roe, J. N., et al., “Bloodless Glucose Measurements”, Critical Review in Therapeutic Drug Carrier Systems, vol. 15, Issue 3, 1998, pp. 199-241. |
| Sakakida, M., et al., “Development of Ferrocene-Mediated Needle-Type Glucose Sensor as a Measure of True Subcutaneous Tissue Glucose Concentrations”, Artificial Organs Today, vol. 2, No. 2, 1992, pp. 145-158. |
| Sakakida, M., et al., “Ferrocene-Mediated Needle-Type Glucose Sensor Covered with Newly Designed Biocompatible Membrane”, Sensors and Actuators B, vol. 13-14, 1993, pp. 319-322. |
| Salehi, C., et al., “A Telemetry-Instrumentation System for Long-Term Implantable Glucose and Oxygen Sensors”, Analytical Letters, vol. 29, No. 13, 1996, pp. 2289-2308. |
| Schmidtke, D. W., et al., “Measurement and Modeling of the Transient Difference Between Blood and Subcutaneous Glucose Concentrations in the Rat After Injection of Insulin”, Proceedings of the National Academy of Sciences, vol. 95, 1998, pp. 294-299. |
| Shaw, G. W., et al., “In Vitro Testing of a Simply Constructed, Highly Stable Glucose Sensor Suitable for Implantation in Diabetic Patients”, Biosensors & Bioelectronics, vol. 6, 1991, pp. 401-406. |
| Shichiri, M., et al., “Glycaemic Control in Pancreatectomized Dogs with a Wearable Artificial Endocrine Pancreas”, Diabetologia, vol. 24, 1983, pp. 179-184. |
| Shichiri, M., et al., “In Vivo Characteristics of Needle-Type Glucose Sensor—Measurements of Subcutaneous Glucose Concentrations in Human Volunteers”, Hormone and Metabolic Research Supplement Series, vol. 20, 1988, pp. 17-20. |
| Shichiri, M., et al., “Membrane Design for Extending the Long-Life of an Implantable Glucose Sensor”, Diabetes Nutrition and Metabolism, vol. 2, 1989, pp. 309-313. |
| Shichiri, M., et al., “Needle-type Glucose Sensor for Wearable Artificial Endocrine Pancreas”, Implantable Sensors for Closed-Loop Prosthetic Systems, Chapter 15, 1985, pp. 197-210. |
| Shichiri, M., et al., “Telemetry Glucose Monitoring Device With Needle-Type Glucose Sensor: A Useful Tool for Blood Glucose Monitoring in Diabetic Individuals”, Diabetes Care, vol. 9, No. 3, 1986, pp. 298-301. |
| Shichiri, M., et al., “Wearable Artificial Endocrine Pancreas With Needle-Type Glucose Sensor”, The Lancet, 1982, pp. 1129-1131. |
| Shults, M. C., et al., “A Telemetry-Instrumentation System for Monitoring Multiple Subcutaneously Implanted Glucose Sensors”, IEEE Transactions on Biomedical Engineering, vol. 41, No. 10, 1994, pp. 937-942. |
| Steil, G. M., et al., “Closed-Loop Insulin Delivery—the Path of Physiological Glucose Control”, Advanced Drug Delivery Reviews, vol. 56, 2004, pp. 125-144. |
| Steil, G. M., et al., “Determination of Plasma Glucose During Rapid Glucose Excursions with a Subcutaneous Glucose Sensor”, Diabetes Technology & Therapeutics, vol. 5, No. 1, 2003, pp. 27-31. |
| Sternberg, R., et al., “Study and Development of Multilayer Needle-Type Enzyme-Based Glucose Microsensors”, Biosensors, vol. 4, 1988, pp. 27-40. |
| Thompson, M., et al., “In Vivo Probes: Problems and Perspectives”, Clinical Biochemistry, vol. 19, 1986, pp. 255-261. |
| Turner, A., et al., “Diabetes Mellitus: Biosensors for Research and Management”, Biosensors, vol. 1, 1985, pp. 85-115. |
| Updike, S. J., et al., “Principles of Long-Term Fully Implanted Sensors with Emphasis on Radiotelemetric Monitoring of Blood Glucose from Inside a Subcutaneous Foreign Body Capsule (FBC)”, Biosensors in the Body: Continuous in vivo Monitoring, Chapter 4, 1997, pp. 117-137. |
| Velho, G., et al., “Strategies for Calibrating a Subcutaneous Glucose Sensor”, Biomedica Biochimica Acta, vol. 48, 1989, pp. 957-964. |
| Whipple, G., “Low Residual Noise Speech Enhancement Utilizing Time-Frequency”, Proceedings of the International Conference on Acoustics, Speech, and Signal Processing, vol. 19, 1994, pp. I5-I8. |
| Wilson, G. S., et al., “Progress Toward the Development of an Implantable Sensor for Glucose”, Clinical Chemistry, vol. 38, No. 9, 1992, pp. 1613-1617. |
| Wolfe, P. J., et al., “Interpolation of Missing Data Values for Audio Signal Restoration Using a Gabor Regression Model”, 2005 IEEE International Conference on Acoustics, Speech, and Signal Processing, vol. 5, 2005, pp. 517-520. |
| European Patent Application No. 13275272.6, Extended European Search Report dated Mar. 3, 2014. |
| U.S. Appl. No. 14/066,650, Notice of Allowance dated Feb. 16, 2017. |
| U.S. Appl. No. 14/066,650, Office Action dated Sep. 23, 2016. |
| U.S. Appl. No. 14/077,004, Office Action dated Jul. 26, 2016. |
| U.S. Appl. No. 15/616,916, Notice of Allowance dated Sep. 7, 2017. |
| U.S. Appl. No. 15/789,949, Notice of Allowance dated Dec. 18, 2018. |
| U.S. Appl. No. 15/789,949, Office Action dated Dec. 4, 2018. |
| U.S. Appl. No. 15/789,949, Office Action dated May 3, 2018. |
| U.S. Appl. No. 15/796,274, Notice of Allowance dated Jul. 20, 2018. |
| U.S. Appl. No. 15/334,274, Office Action dated Apr. 25, 2019. |
| Chen, et al., “A novel fault-tolerant sensor system for sensor drift compensation”, Sensors and Actuators, A 147:623-632 (2008). |
| Gerritsen, et al., “Performance of subcutaneously implanted glucose sensors for continuous monitoring”, The Netherlands Journal of Medicine, 54:167-179 (1999). |
| Kalivas, et al., “Compensation for Drift and Interferences in Multicomponent Analysis”, Laboratory for Chemometrics, Department of Chemistry, University of Washington, 38 pages (1982). |
| Thévenot, et al., “Electrochemical Biosensors: Recommended Definitions and Classification (Technical Report)”, Pure Appl. Chem. 71(12):2333-2348 (1999). |
| U.S. Appl. No. 12/842,013 Office Action mailed Aug. 26, 2015. |
| U.S. Appl. No. 12/842,013 Office Action mailed Mar. 23, 2016. |
| U.S. Appl. No. 12/842,013 Office Action mailed Nov. 6, 2014. |
| Walt, et al., “The chemistry of enzyme and protein immobilization with glutaraldehyde”, Trends in Analytical Chemistry, 13(10):425-430 (1994). |
| Zhang, “Investigations of potentially implantable glucose sensors”, University of Kansas, 24 pages (1991). |
| U.S. Appl. No. 60/687,199, filed Jun. 2, 2005, Ward, et al. |
| U.S. Appl. No. 61/155,889, filed Feb. 26, 2009, Hoss, et al. |
| U.S. Appl. No. 18/173,901, May 25, 2023, Non-Final Office Action. |
| Atanasov, et al., “Implantation of a refillable glucose monitoring-telemetry device”, Biosensors & Bioelectronics, 12(7):669-680 (1997). |
| Bindra, “Development of potentially implantable glucose sensors”, The University of Arizona, 227 pages (1990). |
| Choleau, et al., “Calibration of a subcutaneous amperometric glucose sensor Part 1. Effect of measurement uncertainties on the determination of sensor sensitivity and background current”, Biosensors and Bioelectronics, 17:641-646 (2002). |
| Guardian® Real-Time, Continuous Glucose Monitoring System, User Guide, Medtronic MiniMed, Inc., 184 pages (2006). |
| Kerner, et al., The function of a hydrogen peroxide-detecting electroenzymatic glucose electrode is markedly impaired in human sub-cutaneous tissue and plasma, Biosensors & Bioelectronics, 8:473-482 (1993). |
| Koschinsky, et al., “Sensors for glucose monitoring: technical and clinical aspects”, Diabetes/Metabolism Research and Reviews, 17:113-123 (2001). |
| Koschwanez, et al., “In vitro, in vivo and post explantation testing of glucose-detecting biosensors: Current methods and recommendations”, Biomaterials, 28:3687-3703 (2007). |
| Moussy, et al. “Performance of Subcutaneously Implanted Needle-Type Glucose Sensors Employing a Novel Trilayer Coating”, Anal. Chem., 65:2072-2077 (1993). |
| Pickup, et al., “In vivo glucose sensing for diabetes management: progress towards non-invasive monitoring”, BMJ, 319, pp. 1-4 (1999). |
| Pickup, et al., “Responses and calibration of amperometric glucose sensors implanted in the subcutaneous tissue of man”, Acta Diabetol, 30:143-148 (1993). |
| Schmidtke, et al., “Accuracy of the One-Point in Vivo Calibration of “Wired” Glucose Oxidase Electrodes Implanted in Jugular Veins of Rats in Periods of Rapid Rise and Decline of the Glucose Concentration”, Anal. Chem., 70:2149-2155 (1998). |
| Ward, et al., “Rise in background current over time in a subcutaneous glucose sensor in the rabbit: relevance to calibration and accuracy”, Biosensors & Bioelectronics, 15:53-61 (2000). |
| Wilson, et al., “Biosensors for real-time in vivo measurements”, Biosensors and Bioelectronics, 20:2388-2403 (2005). |
| Wisniewski, et al., “Analyte flux through chronically implanted subcutaneous polyamide membranes differs in humans and rats”, Am J Physiol Endocrinol Metab, 282:E1316-E1323 (2002). |
| Abbott receives CE Mark for Freestyle® Libre, a revolutionary glucose monitoring system for people with diabetes, 8 pages (2023). |
| An Interview with Kevin Sayer, President and CEO of Dexcom, About The New Dexcom G6, 6 pages (2021). |
| Cambridge Dictionary of American English, for the word “recess,” Cambridge University Press, 3 pages (2000). |
| Certified Preliminary Amendment for U.S. Pat. No. 10,827,954, issued on Nov. 10, 2020. |
| Certified Preliminary Amendment for U.S. Pat. No. 10,973,443, issued on Apr. 13, 2021. |
| CGMS Changing Diabetes Management: Kevin Sayer, DIC Interview Transcript, 11 pages (2019). |
| Deciding When to Submit a 510(k) for a Change to an Existing Device, Guidance for Industry and Food and Drug Administration Staff, U.S. Department of Health and Human Services, Food and Drug Administration, 78 pages (2017). |
| Deciding When to Submit a 510(k) for a Software Change to an Existing Device, Guidance for Industry and Food and Drug Administration Staff, U.S. Department of Health and Human Services, Food and Drug Administration, 32 pages (2017). |
| Dexcom (DXCM) / Feb. 27, 2018 / 2017 Q4 Earnings call transcript, 12 pages (2017). |
| DexCom (DXCM) Q1 2018 Results—Earnings Call Transcript, 4 pages (2018). |
| Dexcom CEO—Prime Position in Our Market—Mad Money—CNBC.mp4, 4 pages (2023). |
| Dexcom G6, Continuous Glucose Monitoring System, User Guide, 22 pages (2020). |
| Dexcom G6, Continuous Glucose Monitoring System, User Guide, 7 pages (2020). |
| Dexcom G6, Start Here Set Up, Dexcom G6 Continuous Glucose Monitoring (CGM) System (G6), 8 pages (2019). |
| Dexcom G6, Using Your G6, 7 pages (2020). |
| DexCom, Inc. NasdaqGS:DXCM, Company Conference Presentation, 10 pages (2020). |
| DexCom, Inc. NasdaqGS:DXCM, Company Conference Presentation, 11 pages (2019). |
| DexCom, Inc. NasdaqGS:DXCM, Company Conference Presentation, 17 pages (2021). |
| Email from Sophie Hood to Matthew Werdegar and Manuela Cabal re. Abbott Diabetes Care, Inc et al. v. DexCom, Inc. | Case No. 21-977-KAJ, dated Jan. 24, 2023. |
| FDA News Release, FDA authorizes first fully interoperable continuous glucose monitoring system, streamlines review pathway for similar devices, 3 pages (2018). |
| Figures 13 and 12 of U.S. Pat. No. 10,973,443 B2 issued on Apr. 13, 2021. |
| Hoss, et al., Continuous Glucose Monitoring in Subcutaneous Tissue Using Factory-Calibrated Sensors: A Pilot Study, Diabetes Technology & Therapeutics, vol. 12, No. 8, pp. 591-597 (2010). |
| Hoss, et al., Continuous glucose monitoring in the tissue: Do we really need to calibrate in-Vivo?, Abbott Diabetes Care, 23 pages (2009). |
| Hoss, et al., Feasibility of Factory Calibration for Subcutaneous Glucose Sensors in Subjects with Diabetes, Journal of Diabetes Science and Technology, vol. 8(1), pp. 89-94 (2014). |
| IEEE 100, The Authoritative Dictionary, Seventh Edition, Standards Information Network, IEEE Press, 3 pages (2000). |
| Interview with Dexcom CEO, Dexcom CEO Kevin Sayer Explains G6, Written by: Michelle Boise, 10 pages—Exhibit 113 (2018). |
| Interview with Dexcom CEO, Dexcom CEO Kevin Sayer Explains G6, Written by: Michelle Boise, 10 pages—Exhibit 158 (2018). |
| Interview with Dexcom CEO, Dexcom CEO Kevin Sayer Explains G6, Written by: Michelle Boise, 9 pages (2018). |
| Joint Declaration under 37 C.F.R. § 1.131 for U.S. Appl. No. 15/963,828 (2020). |
| Letter from Department of Health & Human Services to Abbott Diabetes Care, Inc. re. PMA approval for P050020, FreeStyle Navigator Continuous Glucose Monitoring System, dated Mar. 12, 2008. |
| Merriam-Webster's Collegiate Dictionary, Tenth Edition for the words “housing” and “recess,” Merriam-Webster, Incorporated, 4 pages (1999). |
| Merriam-Webster's Collegiate Dictionary, Tenth Edition for the words “release” and “retain,” Merriam-Webster, Incorporated, 4 pages (1999). |
| Non-Final Office Action for U.S. Appl. No. 14/884,622, mailed on Jun. 13, 2018. |
| Non-Final Office Action for U.S. Appl. No. 17/030,030, issued on Dec. 17, 2020. |
| Notice of Allowance for U.S. Appl. No. 15/963,828, mailed on Mar. 3, 2021. |
| Omnipod image, Exhibit 182, 2 pages (Sep. 22, 2022). |
| Program Book, 2nd International Conference on Advanced Technologies & Treatments for Diabetes, Athens, Greece, 4 pages (2009). |
| Response to Non-Final Office Action under 37 C.F.R. 1.111 for U.S. Appl. No. 15/963,828, filed Dec. 8, 2020. |
| Response to Restriction Requirement for U.S. Appl. No. 14/884,622, filed Apr. 5, 2018. |
| Spruce Point Capital Management, Dexcom, Inc., Investment Research Report, Does Dexcom Really Have A Future If It Can't Match Abbott's Scale? 2 pages (Mar. 21, 2019). |
| Tegnestedt, et al., Levels and sources of sound in the intensive care unit—an observational study of three room types, Acta Anaesthesiol Scandinavica Foundation, 11 pages (2013). |
| The Chambers Dictionary for the word “retract,” Chambers Harrap Publishers Ltd, 4 pages (1998). |
| The MiniMed Paradigm® Real-Time Insulin Pump and Continuous Glucose Monitoring System, Insulin Pump User Guide, Medtronic, Paradigm® 522 and 722 Insulin Pumps User Guide, 25 pages (2008). |
| The New Oxford American Dictionary, for the word “retract,” Oxford University Press, 3 pages (2001). |
| The New Penguin English Dictionary, for the word “recess,” Penguin Books, 4 pages (2000). |
| Watkin, An Introduction to Flash Glucose Monitoring, 16 pages (2013). |
| Webster's II New College Dictionary, for the word “alcove,” 2 pages (2001). |
| Webster's Third New International Dictionary of the English Language Unabridged, for the word “retract,” Merriam-Webster Inc., 5 pages (1993). |
| Hoss, U. et al., “Factory-Calibrated Continuous Glucose Sensors: The Science Behind the Technology”, Diabetes Technology & Therapeutics, vol. 19, Suppl. 2, pp. S-44-S-50 (2017). |
| Dock, E. et al., “Multivariate data analysis of dynamic amperometric biosensor responses from binary analyte mixtures—application of sensitivity correction algorithms”, Talanta, 65, pp. 298-305 (2005). |
| Hanson, K. et al., “Comparison of Point Accuracy Between Two Widely Used Continuous Glucose Monitoring Systems”, Journal of Diabetes Science and Technology, 2024, pp. 1-10. |
| Abbott Press Release—“Abbott Receives CE Mark for FreeStyle® Libre, A Revolutionary Glucose Monitoring System for People with Diabetes” retrieved from https://abbott.mediaroom.com/2014-09-03-Abbott-Receives-CE-Mark-for-FreeStyle-Libre-a-Revolutionary-Glucose-Monitoring-System-for-People-with-Diabetes/, Sep. 3, 2014, 3 pages. |
| Abbott Press Release—“Abbott Receives FDA Approval for the FreeStyle Libre Pro™ System, A Revolutionary Diabetes Sensing Technology for Healthcare Professionals to Use with their Patients” retrieved from https://abbott.mediaroom.com/2016-09-28-Abbott-Receives-FDA-Approval-for-the-FreeStyle-Libre-Pro-System-a-Revolutionary-Diabetes-Sensing-Technology-for-Healthcare-Professionals-to-use-with-their-Patients/, Sep. 28, 2016, 5 pages. |
| Abbott Press Release—“Abbott's FreeStyle® Libre 14 Day Flash Glucose Monitoring System Now Approved in U.S.” retrieved from https://abbott.mediaroom.com/2018-07-27-Abbotts-FreeStyle-R-Libre-14-Day-Flash-Glucose-Monitoring-System-Now-Approved-in-U-S/, Jul. 27, 2018, 3 pages. |
| Alcock, et al., “Continuous Analyte Monitoring to Aid Clinical Practice”, IEEE Engineering in Medicine and Biology, vol. 13, No. 3, pp. 319-325 (1994). |
| ANZHSN, National Horizon Scanning Unit Horizon Scanning Report, “GlucoWatch® G2 Biographer for the non-invasive monitoring of glucose levels”, 46 pages, May 2004. |
| Cather, CGM Frustrations Survey dated Jun. 2020, 37 pages in Abbott Diabetes Care Inc., et al. v. Dexcom, Inc., Case No. 1:21-cv-00977-KAJ (District of Delaware). |
| Chen, et al., “In vivo Glucose Monitoring with Miniature “Wired” Glucose Oxidase Electrodes”, Analytical Sciences, vol. 17 Supplement, pp. i297-i300 (2001). |
| Clinical Trials, Competitor and Ecosystem Players dated Jun. 25, 2020, 29 pages in Abbott Diabetes Care Inc., et al. v. Dexcom, Inc., Case No. 1:21-cv-00977-KAJ (District of Delaware). |
| Declaration of Dr. Anthony Edward Cass in Support of Petition for Inter Partes Review of U.S. Pat. No. 11,020,031 in Abbott Diabetes Care Inc. v. Dexcom, Inc., Case No. IPR2024-00890, In the United States Patent and Trademark Office, Before the Patent Trial and Appeal Board, May 10, 2024, 138 pages. |
| Declaratiom of Karl R. Leinsing, MSME, PE, in Support of Abbott's Motion for Summary Judgment dated May 19, 2023, 81 pages in Abbott Diabetes Care Inc., et al. v. Dexcom Inc., Case No. 1:21-CV-00977-KAJ (District of Delaware). |
| Dock, et al., “Multivariate data analysis of dynamic amperometric biosensor responses from binary analyte mixtures—application of sensitivity correction algorithms”, Talanta, 65:298-305 (2005). |
| Effectiveness and Safety Study of the DexCom™ G4 Continuous Glucose Monitoring System, DexCom, Inc, U.S. National Library of Medicine, ClinicalTrials.gov Identifier: NCT01111370, 4 pages (2017). |
| E-mail Communication from Christopher M. Dougherty regarding Bi Monthly Global Commercial Insights Meeting dated Dec. 17, 2019, 69 pages in Abbott Diabetes Care Inc., et al. v. Dexcom, Inc., Case No. 1:21-cv-00977-KAJ (District of Delaware). |
| Feldman, et al., “A Continuous Glucose Sensor Based on Wired Enzyme™ Technology—Results from a 3-Day Trial in Patients with Type 1 Diabetes”, Diabetes Technology & Therapeutics, vol. 5, No. 5, pp. 769-779 (2003). |
| Design U.S. Appl. No. 29/101,218, filed Feb. 25, 1999, 11 pages. |
| U.S. Pat. No. 11,020,031 issued Jun. 1, 2021, 1058 pages. |
| Fraser, “An Introduction to in vivo Biosensing: Progress and Problems”, Biosensors in the Body: Continuous In Vivo Monitoring, pp. 1-56 (1997). |
| FreeStyle Libre 2 HCP Pulse, Mar. 2021 Report, dated Mar. 1, 2021, 14 pages in Abbott Diabetes Care Inc., et al. v. Dexcom, Inc., Case No. 1:21-CV-00977-KAJ (District of Delaware). |
| FreeStyle Navigator Continuous Glucose Monitoring System, User's Guide, Abbott Diabetes Care Inc., 38 pages (2008). |
| Frost, et al., “Implantable chemical sensors for real-time clinical monitoring: progress and challenges”, Current Opinion in Chemical Biology, 6:633-641 (2002). |
| Godek, et al., Chapter 2, “The Macrophage in Wound Healing Surrounding Implanted Devices”, In Vivo Glucose Sensing, 36 pages (2010). |
| Gross, et al., “Performance Evaluation of the MiniMed® Continuous Glucose Monitoring System During Patient Home Use”, Diabetes Technology & Therapeutics, vol. 2, No. 1, pp. 49-56 (2000). |
| Heller, “Implanted Electrochemical Glucose Sensors for the Management of Diabetes”, Annu. Rev. Biomed. Eng., 01:153-175 (1999). |
| Heller, “Integrated Medical Feedback Systems for Drug Delivery”, American Institute of Chemical Engineers Journal, vol. 51, No. 4, pp. 1054-1066 (2005). |
| Heller, et al., “Electrochemical Glucose Sensors and Their Applications in Diabetes Management”, Chem. Rev., 108, Parts 1-3, pp. 2482-2505 (2008). |
| Henning, Chapter 5, “Commercially Available Continuous Glucose Monitoring Systems”, In Vivo Glucose Sensing, 50 pages (2010). |
| Koudelka-Hep, “Electrochemical Sensors for in vivo Glucose Sensing”, Biosensors in the Body: Continuous In Vivo Monitoring, 12 pages (1997). |
| Kovatchev, et al., “Evaluating the Accuracy of Continuous Glucose-Monitoring Sensors”, Diabetes Care, vol. 27, No. 8, pp. 1922-1928 (2004). |
| Lesperance, et al., “Calibration of the Continuous Glucose Monitoring System for Transient Glucose Monitoring”, Diabetes Technology & Therapeutics, vol. 9, No. 2, pp. 183-190 (2007). |
| Nishida, et al., “Development of a ferrocene-mediated needle-type glucose sensor covered with newly designed biocompatible membrane, 2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate”, Medical Progress through Technology, 21:91-103 (1995). |
| Project Status Update, Glucose Sensor Applicator Dexcom (project #2554), Design Concepts, Inc., 6 pages (2014). |
| Schlosser, et al., “Biocompatibility of Active Implantable Devices”, Biosensors in the Body: Continuous in vivo Monitoring, 34 pages (1997). |
| Schmidt, et al., “Calibration of a wearable glucose sensor”, The International Journal of Artificial Organs, vol. 15, No. 1, pp. 55-61 (1992). |
| Seagrove Partners, International Diabetes Device, 2022 Blue Book dated 2022, 143 pages in Abbott Diabetes Care Inc., et al. v. Dexcom, Inc., Case No. 1:21-cv-00977-KAJ (District of Delaware). |
| Velho, et al., “Strategies for calibrating a subcutaneous glucose sensor”, Biomed. Biochim. Acta 48:11/12, pp. 957-964 (1989). |
| Wilson et al., Chapter 1, “Introduction to the Glucose Sensing Problem,” In Vivo Glucose Sensing, 32 pages (2010). |
| Wisniewski, et al., “Characterization of implantable biosensor membrane biofouling”, Fresenius J Anal Chem, 366:611-621 (2000). |
| Dorland's Illustrated Medical 31st Edition Dictionary, definition of “fluid, intersitial”, (2007), 3 pages. |
| Forlenza, G.P., et al., “Factory-Calibrated Continuous Glucose Monitoring: How and Why It Works, and the Dangers of Reuse Beyond Approved Duration of Wear”, Diabetes Technology & Therapeutics, vol. 21, No. 4, (2019) 13 pages. |
| Stephens Inc., Research Bulletin, “DexCom, Inc., A True Game Changer: The G6 Eliminates Fingersticks”, (2018) 5 pages. |
| The American Hertiage® Medical Dictionary, definition of “cathether” and “interstitial fluid”, (2007), 4 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20220142518 A1 | May 2022 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61720393 | Oct 2012 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16256855 | Jan 2019 | US |
| Child | 17580579 | US | |
| Parent | 15789949 | Oct 2017 | US |
| Child | 16256855 | US | |
| Parent | 15616916 | Jun 2017 | US |
| Child | 15789949 | US | |
| Parent | 14066650 | Oct 2013 | US |
| Child | 15616916 | US |